Year |
Citation |
Score |
2022 |
Bulstrode H, Girdler GC, Gracia T, Aivazidis A, Moutsopoulos I, Young AMH, Hancock J, He X, Ridley K, Xu Z, Stockley JH, Finlay J, Hallou C, Fajardo T, Fountain DM, ... ... Watts C, et al. Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells. Neuron. PMID 36174572 DOI: 10.1016/j.neuron.2022.09.002 |
0.372 |
|
2020 |
Kremer AN, Bausenwein J, Lurvink E, Kremer AE, Rutten CE, van Bergen CAM, Kretschmann S, van der Meijden E, Honders MW, Mazzeo D, Watts C, Mackensen A, Falkenburg JHF, Griffioen M. Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase. Frontiers in Immunology. 11: 381. PMID 32218783 DOI: 10.3389/Fimmu.2020.00381 |
0.363 |
|
2018 |
Spiteri I, Caravagna G, Cresswell GD, Vatsiou A, Nichol D, Acar A, Ermini L, Chkhaidze K, Werner B, Mair R, Brognaro E, Verhaak RGW, Sanguinetti G, Piccirillo SGM, Watts C, et al. Evolutionary dynamics of residual disease in human glioblastoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30452544 DOI: 10.1093/Annonc/Mdy506 |
0.315 |
|
2018 |
Maxan A, Mason S, Saint-Pierre M, Smith E, Ho A, Harrower T, Watts C, Tai Y, Pavese N, Savage JC, Tremblay MÈ, Gould P, Rosser AE, Dunnett SB, Piccini P, et al. Outcome of cell suspension allografts in a patient with Huntington's disease. Annals of Neurology. PMID 30286516 DOI: 10.1002/Ana.25354 |
0.613 |
|
2016 |
Palfi S, Gurruchaga JM, Ralph SG, Watts C, Buttery P, Lepetit H, Miskin J, Gouello G, Lavisse S, Fenelon G, Thiriez C, Brugières P, Barker R, Hantraye P, Mitrophanous K. 367. A Dopamine Gene Therapy for Advanced PD: 4 Years Phase I/II Clinical Update Molecular Therapy. 24: S147. DOI: 10.1016/S1525-0016(16)33176-8 |
0.446 |
|
2015 |
Piccirillo SG, Colman S, Potter NE, van Delft FW, Lillis S, Carnicer MJ, Kearney L, Watts C, Greaves M. Genetic and functional diversity of propagating cells in glioblastoma. Stem Cell Reports. 4: 7-15. PMID 25533637 DOI: 10.1016/J.Stemcr.2014.11.003 |
0.314 |
|
2015 |
Piccirillo SGM, Colman S, Potter NE, Delft FWv, Lillis S, Carnicer M, Kearney L, Watts C, Greaves M. Abstract 2318: Genetic and functional diversity of propagating cells in glioblastoma Cancer Research. 75: 2318-2318. DOI: 10.1158/1538-7445.Am2015-2318 |
0.312 |
|
2015 |
Piccirillo SGM, Colman S, Potter N, Delft Fv, Lillis S, Carnicer M, Kearney L, Watts C, Greaves M. Op14Genetic And Functional Diversity Of Propagating Cells In Glioblastoma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov283.14 |
0.319 |
|
2015 |
Watts C, Piccirillo S, Colman S, Potter N, Delft Fv, Lillis S, Carnicer M, Kearney L, Francis N, Venkitaraman A, Greaves M. Atps-93Chemo-Naïve Glioblastoma Patients Contain Genetically Heterogeneous Sub-Clones Capable Of Tumour Propagation And Spatially Heterogeneous Drug-Resistant Cell Populations Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov204.93 |
0.301 |
|
2014 |
Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, Kelleher M, Deeley S, Iwamuro H, Lefaucheur JP, Thiriez C, Fenelon G, Lucas C, et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet. 383: 1138-46. PMID 24412048 DOI: 10.1016/S0140-6736(13)61939-X |
0.445 |
|
2014 |
Kolb A, Trecharichi A, Piccirillo S, Watts C, Price S. OP08 * CHARACTERISATION OF RESIDUAL CELLS IN GLIOBLASTOMA MULTIFORME Neuro-Oncology. 16: vi17-vi17. DOI: 10.1093/Neuonc/Nou251.8 |
0.305 |
|
2014 |
Kolb A, Watts C, Piccirillo S. Dd-06Potentiating The Therapeutic Efficiency Of The Alkylating Chemotherapy Temozolomide In Patients With Glioblastoma. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou246.6 |
0.319 |
|
2014 |
Watts C, Piccirillo S, Kearney L, Potter N, Delft Fv, Coleman S, Lillis S, Carnicer M, Greaves M. Cb-18Interrogation Of Sub-Clonal Genetic Diversity Of Human Gbm Reveals Genetic Heterogeneity In Tumour-Propagating Cells, Which Display Variable Competitive Capacity For Tumour Propagation In Vivo Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou241.17 |
0.306 |
|
2013 |
Antoniades CA, Watts C. Huntington's disease and cell therapies: past, present, and future. Methods in Molecular Biology (Clifton, N.J.). 1010: 19-32. PMID 23754216 DOI: 10.1007/978-1-62703-411-1_2 |
0.321 |
|
2013 |
Barker RA, Mason SL, Harrower TP, Swain RA, Ho AK, Sahakian BJ, Mathur R, Elneil S, Thornton S, Hurrelbrink C, Armstrong RJ, Tyers P, Smith E, Carpenter A, Piccini P, ... ... Watts C, et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 657-65. PMID 23345280 DOI: 10.1136/Jnnp-2012-302441 |
0.615 |
|
2013 |
Piccirillo SGM, Spiteri I, Sottoriva A, Touloumis A, Ber S, Price SJ, Heywood R, Francis N, Collins VP, Venkitaraman AR, Curtis C, Marioni JC, Tavare S, Watts C. Abstract 5016: The human sub-ependymal zone harbors glioblastoma precursors and represents a distinct therapeutic target. Cancer Research. 73: 5016-5016. DOI: 10.1158/1538-7445.Am2013-5016 |
0.309 |
|
2012 |
Heywood RM, Marcus HJ, Ryan DJ, Piccirillo SG, Al-Mayhani TM, Watts C. A review of the role of stem cells in the development and treatment of glioma. Acta Neurochirurgica. 154: 951-69; discussion 9. PMID 22527576 DOI: 10.1007/S00701-012-1338-9 |
0.313 |
|
2012 |
Antoniades CA, Buttery P, FitzGerald JJ, Barker RA, Carpenter RH, Watts C. Deep brain stimulation: eye movements reveal anomalous effects of electrode placement and stimulation. Plos One. 7: e32830. PMID 22427894 DOI: 10.1371/Journal.Pone.0032830 |
0.413 |
|
2012 |
Zou F, Schmon M, Sienczyk M, Grzywa R, Palesch D, Boehm BO, Sun ZL, Watts C, Schirmbeck R, Burster T. Application of a novel highly sensitive activity-based probe for detection of cathepsin G. Analytical Biochemistry. 421: 667-72. PMID 22178917 DOI: 10.1016/J.Ab.2011.11.016 |
0.312 |
|
2011 |
Al-Mayhani MT, Grenfell R, Narita M, Piccirillo S, Kenney-Herbert E, Fawcett JW, Collins VP, Ichimura K, Watts C. NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature. Neuro-Oncology. 13: 830-45. PMID 21798846 DOI: 10.1093/Neuonc/Nor088 |
0.317 |
|
2011 |
Piccirillo SG, Watts C. Abstract 3325: Phenotypic heterogeneity and distribution of human glioblastoma tumour-initiating cells Cancer Research. 71: 3325-3325. DOI: 10.1158/1538-7445.Am2011-3325 |
0.317 |
|
2008 |
Clelland CD, Barker RA, Watts C. Cell therapy in Huntington disease. Neurosurgical Focus. 24: E9. PMID 18341412 DOI: 10.3171/Foc/2008/24/3-4/E8 |
0.49 |
|
2007 |
Joannides AJ, Webber DJ, Raineteau O, Kelly C, Irvine KA, Watts C, Rosser AE, Kemp PJ, Blakemore WF, Compston A, Caldwell MA, Allen ND, Chandran S. Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cells. Brain : a Journal of Neurology. 130: 1263-75. PMID 17472984 DOI: 10.1093/Brain/Awm070 |
0.31 |
|
2003 |
Watts C, Donovan T, Gillard JH, Antoun NM, Burnstein R, Menon DK, Carpenter TA, Fryer T, Thomas DG, Pickard JD. Evaluation of an MRI-based protocol for cell implantation in four patients with Huntington's disease. Cell Transplantation. 12: 697-704. PMID 14653617 DOI: 10.3727/000000003108747316 |
0.335 |
|
2002 |
Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, Burnstein RM, Menon DK, Gillard JH, Pickard J, Dunnett SB. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. Journal of Neurology, Neurosurgery, and Psychiatry. 73: 678-85. PMID 12438470 DOI: 10.1136/Jnnp.73.6.678 |
0.606 |
|
2001 |
Manoury B, Gregory WF, Maizels RM, Watts C. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Current Biology. 11: 447-451. PMID 11301256 DOI: 10.1016/S0960-9822(01)00118-X |
0.311 |
|
2000 |
Armstrong RJE, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, Neuronal Differentiation, and Fiber Outgrowth of Propagated Human Neural Precursor Grafts in an Animal Model of Huntington's Disease. Cell Transplantation. 9: 55-64. PMID 28876110 DOI: 10.1177/096368970000900108 |
0.611 |
|
2000 |
Watts C, Amigorena S. Antigen traffic pathways in dendritic cells. Traffic. 1: 312-317. PMID 11208116 DOI: 10.1034/J.1600-0854.2000.010404.X |
0.302 |
|
2000 |
Watts C, Brasted PJ, Dunnett SB. The morphology, integration, and functional efficacy of striatal grafts differ between cell suspensions and tissue pieces. Cell Transplantation. 9: 395-407. PMID 10972338 DOI: 10.1177/096368970000900310 |
0.773 |
|
2000 |
Brasted PJ, Watts C, Torres EM, Robbins TW, Dunnett SB. Behavioral recovery after transplantation into a rat model of Huntington's disease: dependence on anatomical connectivity and extensive postoperative training. Behavioral Neuroscience. 114: 431-6. PMID 10832803 DOI: 10.1037//0735-7044.114.2.431 |
0.765 |
|
2000 |
Watts C, Dunnett SB. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease. Cell Transplantation. 9: 223-34. PMID 10811395 DOI: 10.1177/096368970000900208 |
0.507 |
|
2000 |
Watts C, Brasted PJ, Dunnett SB. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease. Experimental Neurology. 163: 85-97. PMID 10785447 DOI: 10.1006/Exnr.1999.7341 |
0.767 |
|
2000 |
Watts C, McNamara IR, Dunnett SB. Volume and differentiation of striatal grafts in rats: relationship to the number of cells implanted. Cell Transplantation. 9: 65-72. PMID 10784068 DOI: 10.1177/096368970000900109 |
0.518 |
|
2000 |
Armstrong RJ, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplantation. 9: 55-64. PMID 10784067 DOI: 10.1177/096368970000900108 |
0.642 |
|
1999 |
Watts C. Dendritic cells spill the beans. Nature Cell Biology. 1. PMID 10559977 DOI: 10.1038/14105 |
0.304 |
|
1999 |
Brasted PJ, Watts C, Torres EM, Robbins TW, Dunnett SB. Behavioural recovery following striatal transplantation: effects of postoperative training and P-zone volume. Experimental Brain Research. 128: 535-8. PMID 10541748 DOI: 10.1007/S002210050877 |
0.762 |
|
1999 |
Brasted PJ, Watts C, Robbins TW, Dunnett SB. Associative plasticity in striatal transplants. Proceedings of the National Academy of Sciences of the United States of America. 96: 10524-9. PMID 10468642 DOI: 10.1073/Pnas.96.18.10524 |
0.763 |
|
1998 |
Dunnett SB, Carter RJ, Watts C, Torres EM, Mahal A, Mangiarini L, Bates G, Morton AJ. Striatal transplantation in a transgenic mouse model of Huntington's disease. Experimental Neurology. 154: 31-40. PMID 9875265 DOI: 10.1006/Exnr.1998.6926 |
0.495 |
|
1998 |
Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, Watts C. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation Nature. 396: 695-699. PMID 9872320 DOI: 10.1038/25379 |
0.302 |
|
1998 |
Watts C, Caldwell MA, Dunnett SB. The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplantation. 7: 573-83. PMID 9853586 DOI: 10.1016/S0963-6897(98)00034-7 |
0.506 |
|
1998 |
Watts C, Dunnett SB. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention. Journal of Neurosurgery. 89: 267-74. PMID 9688122 DOI: 10.3171/Jns.1998.89.2.0267 |
0.523 |
|
1997 |
Dunnett SB, Kendall AL, Watts C, Torres EM. Neuronal cell transplantation for Parkinson's and Huntington's diseases. British Medical Bulletin. 53: 757-76. PMID 9536526 |
0.456 |
|
1997 |
Watts C, Dunnett SB, Rosser AE. Effect of embryonic donor age and dissection on the DARPP-32 content of cell suspensions used for intrastriatal transplantation. Experimental Neurology. 148: 271-80. PMID 9398469 DOI: 10.1006/Exnr.1997.6646 |
0.511 |
|
1997 |
Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. European Journal of Immunology. 27: 280-8. PMID 9022030 DOI: 10.1002/Eji.1830270141 |
0.308 |
|
1994 |
Barnaba V, Watts C, Boer Md, Lane P, Lanzavecchia A. Professional presentation of antigen by activated human T cells. European Journal of Immunology. 24: 71-75. PMID 7517364 DOI: 10.1002/Eji.1830240112 |
0.3 |
|
Low-probability matches (unlikely to be authored by this person) |
2016 |
Nourallah B, Digpal R, Jena R, Watts C. Irradiating the Subventricular Zone in Glioblastoma Patients: Is there a Case for a Clinical Trial? Clinical Oncology (Royal College of Radiologists (Great Britain)). 29: 26-33. PMID 27729188 DOI: 10.1016/J.Clon.2016.09.005 |
0.3 |
|
1999 |
Watts C. Book Review: Cell Transplantation for Neurological Disorders. Towards Reconstruction of the Human Central Nervous System Cell Transplantation. 8: 567-569. DOI: 10.1177/096368979900800512 |
0.299 |
|
2019 |
Watts C, Apps J, Ansorg O, Savage J, Fox R, Chalmers A, Short SC, Thompson G, Waldman A, Capper D, Hargrave D, Brennan P, Smith S, Ashkan K, Wykes V, et al. RBTT-06. TESSA JOWELL BRAIN MATRIX STUDY: A BRITISH FEASIBILITY STUDY OF MOLECULAR STRATIFICATION AND TARGETED THERAPY TO OPTIMIZE THE CLINICAL MANAGEMENT OF PATIENTS WITH GLIOMA Neuro-Oncology. 21: vi219-vi220. DOI: 10.1093/Neuonc/Noz175.918 |
0.299 |
|
1995 |
Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages Immunity. 3: 783-791. PMID 8777723 DOI: 10.1016/1074-7613(95)90067-5 |
0.298 |
|
2014 |
Piccirillo SGM, Spiteri I, Sottoriva A, Touloumis A, Collins P, Curtis C, Marioni J, Tavare' S, Watts C. O4.05 * GENETIC DIVERSITY AND INTRA-TUMOR HETEROGENEITY IN HUMAN GLIOBLASTOMA Neuro-Oncology. 16: ii8-ii8. DOI: 10.1093/Neuonc/Nou174.26 |
0.298 |
|
2017 |
Mallett G, Gangaplara A, Stathopolou C, Flomerfelt F, Samsel L, Felizardo T, Eckhaus M, Edgington L, Yim J, Martinez-Fabregas J, Zhu J, Fowler DH, Bogyo M, van-Kasteren S, Watts C, et al. PD-1 through Asparaginyl Endopeptidase Regulates Foxp3 Stability in Induced Regulatory T Cells Blood. 130: 4438-4438. DOI: 10.1182/Blood.V130.Suppl_1.4438.4438 |
0.297 |
|
2018 |
Abdul KU, Houweling M, Svensson F, Narayan RS, Cornelissen FMG, Küçükosmanoglu A, Metzakopian E, Watts C, Bailey D, Wurdinger T, Westerman BA. WINDOW consortium: A path towards increased therapy efficacy against glioblastoma. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 40: 17-24. PMID 30439622 DOI: 10.1016/J.Drup.2018.10.001 |
0.296 |
|
2003 |
Loak K, Li DN, Manoury B, Billson J, Morton F, Hewitt E, Watts C. Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase. Biological Chemistry. 384: 1239-46. PMID 12974392 DOI: 10.1515/Bc.2003.136 |
0.295 |
|
2018 |
Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt FA, Liniany LP, Knight D, Samsel LA, Berlinguer-Palmini R, Yim JJ, Felizardo TC, Eckhaus MA, Edgington-Mitchell L, Martinez-Fabregas J, Zhu J, Fowler DH, ... ... Watts C, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. PMID 30054205 DOI: 10.1016/J.Immuni.2018.05.006 |
0.294 |
|
2009 |
Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, Collins PV, Watts C. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. Journal of Neuroscience Methods. 176: 192-9. PMID 19215724 DOI: 10.1016/J.Jneumeth.2008.07.022 |
0.293 |
|
1995 |
Corradin G, Watts C. Cellular Immunology of Tetanus Toxoid Current Topics in Microbiology and Immunology. 195: 77-87. PMID 8542760 DOI: 10.1007/978-3-642-85173-5_4 |
0.293 |
|
2018 |
Rowland MJ, Parkins CC, McAbee JH, Kolb AK, Hein R, Loh XJ, Watts C, Scherman OA. An adherent tissue-inspired hydrogel delivery vehicle utilised in primary human glioma models. Biomaterials. 179: 199-208. PMID 30037456 DOI: 10.1016/J.Biomaterials.2018.05.054 |
0.292 |
|
1989 |
Davidson HW, Watts C. Epitope-directed processing of specific antigen by B lymphocytes. Journal of Cell Biology. 109: 85-92. PMID 2473083 DOI: 10.1083/Jcb.109.1.85 |
0.291 |
|
2010 |
Matthews SP, Werber I, Deussing J, Peters C, Reinheckel T, Watts C. Distinct protease requirements for antigen presentation in vitro and in vivo. Journal of Immunology (Baltimore, Md. : 1950). 184: 2423-31. PMID 20164435 DOI: 10.4049/Jimmunol.0901486 |
0.29 |
|
2014 |
Ajaz M, Jefferies S, Brazil L, Watts C, Chalmers A. Current and investigational drug strategies for glioblastoma Clinical Oncology. 26: 419-430. PMID 24768122 DOI: 10.1016/J.Clon.2014.03.012 |
0.29 |
|
2012 |
Watts C. The endosome-lysosome pathway and information generation in the immune system. Biochimica Et Biophysica Acta. 1824: 14-21. PMID 21782984 DOI: 10.1016/J.Bbapap.2011.07.006 |
0.29 |
|
2005 |
Watts C, McConkey H, Anderson L, Caldwell M. Anatomical perspectives on adult neural stem cells. Journal of Anatomy. 207: 197-208. PMID 16185244 DOI: 10.1111/J.1469-7580.2005.00448.X |
0.29 |
|
2013 |
Stricker SH, Feber A, Engström PG, Carén H, Kurian KM, Takashima Y, Watts C, Way M, Dirks P, Bertone P, Smith A, Beck S, Pollard SM. Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. Genes & Development. 27: 654-69. PMID 23512659 DOI: 10.1101/Gad.212662.112 |
0.289 |
|
2019 |
Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, ... ... Watts C, et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature. PMID 31748746 DOI: 10.1038/S41586-019-1775-1 |
0.289 |
|
1988 |
Watts C, Davidson HW. Endocytosis and recycling of specific antigen by human B cell lines The Embo Journal. 7: 1937-1945. DOI: 10.1002/J.1460-2075.1988.Tb03031.X |
0.289 |
|
2005 |
Moss CX, Villadangos JA, Watts C. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing. European Journal of Immunology. 35: 3442-51. PMID 16259009 DOI: 10.1002/Eji.200535320 |
0.289 |
|
2000 |
West MA, Prescott AR, Eskelinen EL, Ridley AJ, Watts C. Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Current Biology : Cb. 10: 839-48. PMID 10899002 DOI: 10.1016/S0960-9822(00)00595-9 |
0.288 |
|
1995 |
Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. Journal of Experimental Medicine. 181: 1957-1963. PMID 7539034 DOI: 10.1084/Jem.181.6.1957 |
0.288 |
|
2007 |
Moss CX, Tree TI, Watts C. Reconstruction of a pathway of antigen processing and class II MHC peptide capture. The Embo Journal. 26: 2137-47. PMID 17396153 DOI: 10.1038/Sj.Emboj.7601660 |
0.288 |
|
1993 |
Watts C, Lanzavecchia A. Suppressive effect of antibody on processing of T cell epitopes. Journal of Experimental Medicine. 178: 1459-1463. PMID 7690836 DOI: 10.1084/Jem.178.4.1459 |
0.287 |
|
2014 |
Setua S, Ouberai M, Piccirillo SG, Watts C, Welland M. Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma. Nanoscale. 6: 10865-73. PMID 25117686 DOI: 10.1039/C4Nr03693J |
0.287 |
|
1998 |
Watts C, Antoniou A, Manoury B, Hewitt EW, Mckay LM, Grayson L, Fairweather NF, Emsley P, Isaacs N, Simitsek PD. Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen Immunological Reviews. 164: 11-16. PMID 9795759 DOI: 10.1111/J.1600-065X.1998.Tb01203.X |
0.285 |
|
2005 |
Moss CX, Matthews SP, Lamont DJ, Watts C. Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules. The Journal of Biological Chemistry. 280: 18498-503. PMID 15749706 DOI: 10.1074/Jbc.M501241200 |
0.283 |
|
2005 |
Murray J, Manoury B, Balic A, Watts C, Maizels RM. Bm-CPI-2, a cystatin from Brugia malayi nematode parasites, differs from Caenorhabditis elegans cystatins in a specific site mediating inhibition of the antigen-processing enzyme AEP. Molecular and Biochemical Parasitology. 139: 197-203. PMID 15664654 DOI: 10.1016/J.Molbiopara.2004.11.008 |
0.283 |
|
2000 |
Antoniou AN, Blackwood SL, Mazzeo D, Watts C. Control of antigen presentation by a single protease cleavage site. Immunity. 12: 391-8. PMID 10795737 DOI: 10.1016/S1074-7613(00)80191-0 |
0.283 |
|
2002 |
Antoniou AN, Watts C. Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcgammaRII. European Journal of Immunology. 32: 530-40. PMID 11828370 DOI: 10.1002/1521-4141(200202)32:2<530::Aid-Immu530>3.0.Co;2-X |
0.282 |
|
2015 |
Carruthers R, Ahmed SU, Strathdee K, Gomez-Roman N, Amoah-Buahin E, Watts C, Chalmers AJ. Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase. Molecular Oncology. 9: 192-203. PMID 25205037 DOI: 10.1016/J.Molonc.2014.08.003 |
0.282 |
|
2013 |
Sottoriva A, Spiteri I, Piccirillo SG, Touloumis A, Collins VP, Marioni JC, Curtis C, Watts C, Tavaré S. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proceedings of the National Academy of Sciences of the United States of America. 110: 4009-14. PMID 23412337 DOI: 10.1073/Pnas.1219747110 |
0.282 |
|
2012 |
Watts C. Umbilical cord stem cells: the hidden swan in a family of ugly ducklings. Acta Neurochirurgica. 154: 1727. PMID 22752731 DOI: 10.1007/S00701-012-1430-1 |
0.282 |
|
1990 |
Reid PA, Watts C. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature. 346: 655-7. PMID 2166918 DOI: 10.1038/346655A0 |
0.281 |
|
2003 |
Watts C, Mazzeo D, West MA, Matthews SP, Keane D, Hamilton G, Persson LV, Lawson JM, Manoury B, Moss CX. Roles for asparagine endopeptidase in class II MHC-restricted antigen processing. Biochemical Society Symposium. 31-8. PMID 14587280 DOI: 10.1042/Bss0700031 |
0.281 |
|
2003 |
Watts C, Moss CX, Mazzeo D, West MA, Matthews SP, Li DN, Manoury B. Creation versus destruction of T cell epitopes in the class II MHC pathway. Annals of the New York Academy of Sciences. 987: 9-14. PMID 12727619 DOI: 10.1111/J.1749-6632.2003.Tb06028.X |
0.281 |
|
2015 |
Piccirillo SG, Spiteri I, Sottoriva A, Touloumis A, Ber S, Price SJ, Heywood R, Francis NJ, Howarth KD, Collins VP, Venkitaraman AR, Curtis C, Marioni JC, Tavaré S, Watts C. Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone. Cancer Research. 75: 194-202. PMID 25406193 DOI: 10.1158/0008-5472.Can-13-3131 |
0.28 |
|
2013 |
Lek HS, Morrison VL, Conneely M, Campbell PA, McGloin D, Kliche S, Watts C, Prescott A, Fagerholm SC. The spontaneously adhesive leukocyte function-associated antigen-1 (LFA-1) integrin in effector T cells mediates rapid actin- and calmodulin-dependent adhesion strengthening to ligand under shear flow. The Journal of Biological Chemistry. 288: 14698-708. PMID 23585567 DOI: 10.1074/Jbc.M112.430918 |
0.28 |
|
2004 |
West MA, Wallin RP, Matthews SP, Svensson HG, Zaru R, Ljunggren HG, Prescott AR, Watts C. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science (New York, N.Y.). 305: 1153-7. PMID 15326355 DOI: 10.1126/Science.1099153 |
0.279 |
|
1991 |
Davidson HW, Reid PA, Lanzavecchia A, Watts C. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell. 67: 105-16. PMID 1913812 DOI: 10.1016/0092-8674(91)90575-J |
0.279 |
|
2014 |
Morrison VL, James MJ, Grzes K, Cook P, Glass DG, Savinko T, Lek HS, Gawden-Bone C, Watts C, Millington OR, MacDonald AS, Fagerholm SC. Loss of beta2-integrin-mediated cytoskeletal linkage reprogrammes dendritic cells to a mature migratory phenotype. Nature Communications. 5: 5359. PMID 25348463 DOI: 10.1038/Ncomms6359 |
0.279 |
|
2003 |
Li DN, Matthews SP, Antoniou AN, Mazzeo D, Watts C. Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. The Journal of Biological Chemistry. 278: 38980-90. PMID 12860980 DOI: 10.1074/Jbc.M305930200 |
0.278 |
|
2018 |
Mair R, Wright A, Ros S, Hu DE, Booth TC, Kreis F, Rao J, Watts C, Brindle KM. Metabolic imaging detects low levels of glycolytic activity that vary with levels of c-Myc expression in patient-derived xenograft models of glioblastoma. Cancer Research. PMID 30054337 DOI: 10.1158/0008-5472.Can-18-0759 |
0.278 |
|
2001 |
Watts C. Antigen presentation - Losing its shine in the absence, of GILT Science. 294: 1294-1295. PMID 11701917 DOI: 10.1126/Science.1066725 |
0.278 |
|
2007 |
Patel N, Krishnan S, Offman MN, Moss CX, Ariffin H, vanDelft FW, Yiannikouris O, Leighton C, Alexander S, Holland M, Khater D, Liu JZ, Essink M, Bates P, Watts C, et al. Lymphoblasts Produce a Lysosomal Protease That Rapidly Degrades L-Asparaginase - Implications for Therapy in Childhood Acute Lymphoblastic Leukemia. Blood. 110: 2791-2791. DOI: 10.1182/Blood.V110.11.2791.2791 |
0.276 |
|
2005 |
Watts C, Matthews SP, Mazzeo D, Manoury B, Moss CX. Asparaginyl endopeptidase: case history of a class II MHC compartment protease. Immunological Reviews. 207: 218-28. PMID 16181339 DOI: 10.1111/J.0105-2896.2005.00312.X |
0.276 |
|
2012 |
Piccirillo SG, Dietz S, Madhu B, Griffiths J, Price SJ, Collins VP, Watts C. Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin. British Journal of Cancer. 107: 462-8. PMID 22722315 DOI: 10.1038/Bjc.2012.271 |
0.276 |
|
2012 |
Birks S, Altinkaya M, Altinkaya A, Pilkington G, Kurian KM, Crosby C, Hopkins K, Williams M, Donovan L, Birks S, Eason A, Bosak V, Pilkington G, Birks S, Holliday J, ... ... Watts C, ... ... Watts C, ... ... Watts C, et al. Abstracts from the 2012 BNOS Conference Neuro-Oncology. 14: ii1-ii12. DOI: 10.1093/Neuonc/Nos198 |
0.276 |
|
2012 |
Appel EA, Rowland MJ, Loh XJ, Heywood RM, Watts C, Scherman OA. Enhanced stability and activity of temozolomide in primary glioblastoma multiforme cells with cucurbit[n]uril. Chemical Communications (Cambridge, England). 48: 9843-5. PMID 22936104 DOI: 10.1039/C2Cc35131E |
0.276 |
|
2014 |
Watts C, Price SJ, Santarius T. Current concepts in the surgical management of glioma patients. Clinical Oncology (Royal College of Radiologists (Great Britain)). 26: 385-94. PMID 24882149 DOI: 10.1016/J.Clon.2014.04.001 |
0.276 |
|
2009 |
Zhao JW, Raha-Chowdhury R, Fawcett JW, Watts C. Astrocytes and oligodendrocytes can be generated from NG2+ progenitors after acute brain injury: intracellular localization of oligodendrocyte transcription factor 2 is associated with their fate choice. The European Journal of Neuroscience. 29: 1853-69. PMID 19473238 DOI: 10.1111/J.1460-9568.2009.06736.X |
0.275 |
|
1995 |
Barbey C, Watts C, Corradin G. Antigen-processing organelles from DRB1*1101 and DRB1*1104 B cell lines display a differential degradation activity European Journal of Immunology. 25: 30-36. PMID 7843248 DOI: 10.1002/Eji.1830250107 |
0.275 |
|
2004 |
Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nature Immunology. 5: 685-92. PMID 15224094 DOI: 10.1038/Ni1088 |
0.275 |
|
2014 |
Kolb AK, Piccirillo S, Watts C. P03.04 * SENSITIZING GLIOBLASTOMA CELLS TO THERAPY BY TARGETING THE L-GLUTAMATE/L-CYSTINE ANTIPORTER SYSTEM XC- Neuro-Oncology. 16: ii34-ii35. DOI: 10.1093/Neuonc/Nou174.127 |
0.275 |
|
2018 |
Mair R, Mouliere F, Smith CG, Chandrananda D, Gale D, Marass F, Tsui DWY, Massie CE, Wright AJ, Watts C, Rosenfeld N, Brindle KM. Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models. Cancer Research. PMID 30389699 DOI: 10.1158/0008-5472.Can-18-0074 |
0.275 |
|
2016 |
Sinha R, Sage W, Watts C. The evolving clinical management of cerebral metastases. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 27986364 DOI: 10.1016/J.Ejso.2016.10.006 |
0.275 |
|
2014 |
Watts C, Piccirillo S, Spiteri I, Sottoriva A, Touloumis A, Marioni J, Curtis C, Tavare S. COMPLEX EVOLUTIONARY DYNAMICS GENERATES GENETIC DIVERSITY AND INTRA-TUMOR HETEROGENEITY IN INDIVIDUAL PATIENTS WITH GLIOBLASTOMA Neuro-Oncology. 16: iii7-iii7. DOI: 10.1093/Neuonc/Nou206.23 |
0.274 |
|
2018 |
Collord G, Tarpey P, Kurbatova N, Martincorena I, Moran S, Castro M, Nagy T, Bignell G, Maura F, Young MD, Berna J, Tubio JMC, McMurran CE, Young AMH, Sanders M, ... ... Watts C, et al. An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures. Scientific Reports. 8: 13537. PMID 30202034 DOI: 10.1038/S41598-018-31659-0 |
0.274 |
|
2018 |
Aldape K, Amin SB, Ashley DM, Barnholtz-Sloan JS, Bates AJ, Beroukhim R, Bock C, Brat DJ, Claus EB, Costello JF, de Groot JF, Finocchiaro G, French PJ, Gan HK, Griffith B, ... ... Watts C, et al. Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. Neuro-Oncology. PMID 29432615 DOI: 10.1093/Neuonc/Noy020 |
0.274 |
|
1999 |
West MA, Antoniou AN, Prescott AR, Azuma T, Kwiatkowski DJ, Watts C. Membrane ruffling, macropinocytosis and antigen presentation in the absence of gelsolin in murine dendritic cells. European Journal of Immunology. 29: 3450-5. PMID 10556799 DOI: 10.1002/(Sici)1521-4141(199911)29:11<3450::Aid-Immu3450>3.0.Co;2-A |
0.274 |
|
2020 |
Akkari L, Bowman RL, Tessier J, Klemm F, Handgraaf SM, de Groot M, Quail DF, Tillard L, Gadiot J, Huse JT, Brandsma D, Westerga J, Watts C, Joyce JA. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. Science Translational Medicine. 12. PMID 32669424 DOI: 10.1126/Scitranslmed.Aaw7843 |
0.272 |
|
2015 |
Ahmed SU, Carruthers R, Gilmour L, Yildirim S, Watts C, Chalmers AJ. Selective inhibition of parallel DNA damage response pathways optimizes radiosensitization of glioblastoma stem-like cells. Cancer Research. PMID 26282173 DOI: 10.1158/0008-5472.Can-14-3790 |
0.272 |
|
2016 |
Matthews SP, McMillan SJ, Colbert JD, Lawrence RA, Watts C. Cystatin F Ensures Eosinophil Survival by Regulating Granule Biogenesis. Immunity. PMID 27067058 DOI: 10.1016/J.Immuni.2016.03.003 |
0.272 |
|
1994 |
West MA, Lucocq JM, Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells Nature. 369: 147-151. PMID 8177319 DOI: 10.1038/369147A0 |
0.271 |
|
2017 |
Sage W, Guilfoyle M, Luney C, Young A, Sinha R, Sgubin D, McAbee JH, Ma R, Jefferies S, Jena R, Harris F, Allinson K, Matys T, Qian W, Santarius T, ... ... Watts C, et al. Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit. Journal of Neuro-Oncology. PMID 29139095 DOI: 10.1007/S11060-017-2649-8 |
0.271 |
|
2010 |
Iovino M, Patani R, Watts C, Chandran S, Spillantini MG. Human stem cell-derived neurons: a system to study human tau function and dysfunction. Plos One. 5: e13947. PMID 21085657 DOI: 10.1371/Journal.Pone.0013947 |
0.271 |
|
2014 |
Watts C, Wanek K, Smith P, Counsell N. O5.04Preliminary Results Of The Gala-5 Study: An Evaluation Of The Tolerability And Feasibility Of Combining 5-Amino-Levulinic Acid (5-Ala) With Carmustine Wafers (Gliadel) In The Surgical Management Of Primary Glioblastoma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou174.35 |
0.271 |
|
2004 |
Watts C. Class II MHC: sweetening the peptide only diet? Cell. 117: 558-9. PMID 15163404 DOI: 10.1016/J.Cell.2004.05.007 |
0.27 |
|
2013 |
Price SJ, Guilfoyle M, J Jefferies S, Harris F, Oberg I, G Burnet N, Santarius T, Watts C. Development of an Integrated Subspecialist Multidisciplinary Neuro-oncology Service. Bmj Quality Improvement Reports. 2. PMID 26734207 DOI: 10.1136/Bmjquality.U201857.W981 |
0.27 |
|
1994 |
Hewlett LJ, Prescott AR, Watts C. The coated pit and macropinocytic pathways serve distinct endosome populations. The Journal of Cell Biology. 124: 689-703. PMID 8120092 DOI: 10.1083/Jcb.124.5.689 |
0.269 |
|
2015 |
Rasul FT, Watts C. Novel Surgical Approaches to High-Grade Gliomas. Current Treatment Options in Neurology. 17: 369. PMID 26178621 DOI: 10.1007/S11940-015-0369-Y |
0.269 |
|
1997 |
Watts C. Capture And Processing Of Exogenous Antigens For Presentation On Mhc Molecules Annual Review of Immunology. 15: 821-850. PMID 9143708 DOI: 10.1146/Annurev.Immunol.15.1.821 |
0.268 |
|
1992 |
Lanzavecchia A, Reid PA, Watts C. Irreversible association of peptides with class II MHC molecules in living cells. Nature. 357: 249-52. PMID 1375347 DOI: 10.1038/357249A0 |
0.268 |
|
1997 |
Watts C. Inside the gearbox of the dendritic cell Nature. 388: 724-725. PMID 9285579 DOI: 10.1038/41900 |
0.267 |
|
2015 |
Watts C, Piccirillo SG. Corrigendum. Future Oncology (London, England). 11: 2851. PMID 26358184 DOI: 10.2217/Fon.15.234 |
0.266 |
|
2018 |
Martínez-Fábregas J, Prescott A, van Kasteren S, Pedrioli DL, McLean I, Moles A, Reinheckel T, Poli V, Watts C. Lysosomal protease deficiency or substrate overload induces an oxidative-stress mediated STAT3-dependent pathway of lysosomal homeostasis. Nature Communications. 9: 5343. PMID 30559339 DOI: 10.1038/S41467-018-07741-6 |
0.266 |
|
2011 |
Guilfoyle MR, Weerakkody RA, Oswal A, Oberg I, Jeffery C, Haynes K, Kullar PJ, Greenberg D, Jefferies SJ, Harris F, Price SJ, Thomson S, Watts C. Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme. British Journal of Cancer. 104: 1810-5. PMID 21610702 DOI: 10.1038/Bjc.2011.153 |
0.265 |
|
2018 |
Freeley S, Cardone J, Günther SC, West EE, Reinheckel T, Watts C, Kemper C, Kolev MV. Asparaginyl Endopeptidase (Legumain) Supports Human Th1 Induction via Cathepsin L-Mediated Intracellular C3 Activation. Frontiers in Immunology. 9: 2449. PMID 30405635 DOI: 10.3389/Fimmu.2018.02449 |
0.264 |
|
2007 |
Watts C, Zaru R, Prescott AR, Wallin RP, West MA. Proximal effects of Toll-like receptor activation in dendritic cells. Current Opinion in Immunology. 19: 73-8. PMID 17142025 DOI: 10.1016/J.Coi.2006.11.014 |
0.264 |
|
2007 |
Ozen I, Galichet C, Watts C, Parras C, Guillemot F, Raineteau O. Proliferating neuronal progenitors in the postnatal hippocampus transiently express the proneural gene Ngn2. The European Journal of Neuroscience. 25: 2591-603. PMID 17466019 DOI: 10.1111/J.1460-9568.2007.05541.X |
0.264 |
|
2010 |
Watts C, West MA, Zaru R. TLR signalling regulated antigen presentation in dendritic cells. Current Opinion in Immunology. 22: 124-30. PMID 20083398 DOI: 10.1016/J.Coi.2009.12.005 |
0.263 |
|
1998 |
Molloy Pe, Harris WJ, Strachan G, Watts C, Cunningham C. Production of soluble single-chain T-cell receptor fragments in Escherichia coli trxB mutants Molecular Immunology. 35: 73-81. PMID 9683253 DOI: 10.1016/S0161-5890(98)00019-4 |
0.263 |
|
2002 |
Manoury B, Mazzeo D, Fugger L, Viner N, Ponsford M, Streeter H, Mazza G, Wraith DC, Watts C. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nature Immunology. 3: 169-74. PMID 11812994 DOI: 10.1038/Ni754 |
0.263 |
|
2011 |
van Kasteren SI, Berlin I, Colbert JD, Keane D, Ovaa H, Watts C. A multifunctional protease inhibitor to regulate endolysosomal function. Acs Chemical Biology. 6: 1198-204. PMID 21910425 DOI: 10.1021/Cb200292C |
0.261 |
|
2017 |
Raiber EA, Beraldi D, Martínez Cuesta S, McInroy GR, Kingsbury Z, Becq J, James T, Lopes M, Allinson K, Field S, Humphray S, Santarius T, Watts C, Bentley D, Balasubramanian S. Base resolution maps reveal the importance of 5-hydroxymethylcytosine in a human glioblastoma. Npj Genomic Medicine. 2: 6. PMID 29263824 DOI: 10.1038/S41525-017-0007-6 |
0.26 |
|
2014 |
Maher K, Konjar S, Watts C, Turk B, Kopitar-Jerala N. Cystatin F regulates proteinase activity in IL-2-activated natural killer cells. Protein and Peptide Letters. 21: 957-65. PMID 24702263 DOI: 10.2174/0929866521666140403124146 |
0.26 |
|
2019 |
Tabet A, Jensen MP, Parkins CC, Patil PG, Watts C, Scherman OA. Designing Next-Generation Local Drug Delivery Vehicles for Glioblastoma Adjuvant Chemotherapy: Lessons from the Clinic. Advanced Healthcare Materials. e1801391. PMID 30632715 DOI: 10.1002/Adhm.201801391 |
0.26 |
|
2010 |
Gawden-Bone C, Zhou Z, King E, Prescott A, Watts C, Lucocq J. Dendritic cell podosomes are protrusive and invade the extracellular matrix using metalloproteinase MMP-14. Journal of Cell Science. 123: 1427-37. PMID 20356925 DOI: 10.1242/Jcs.056515 |
0.259 |
|
2008 |
Svensson HG, West MA, Mollahan P, Prescott AR, Zaru R, Watts C. A role for ARF6 in dendritic cell podosome formation and migration. European Journal of Immunology. 38: 818-28. PMID 18286566 DOI: 10.1002/Eji.200737331 |
0.259 |
|
2015 |
Watts C. Clonal diversity in glioblastoma: is it clinically relevant? Future Oncology (London, England). 11: 1703-6. PMID 26075436 DOI: 10.2217/Fon.15.73 |
0.259 |
|
2009 |
Patel N, Krishnan S, Offman MN, Krol M, Moss CX, Leighton C, van Delft FW, Holland M, Liu J, Alexander S, Dempsey C, Ariffin H, Essink M, Eden TO, Watts C, et al. A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase. The Journal of Clinical Investigation. 119: 1964-73. PMID 19509471 DOI: 10.1172/Jci37977 |
0.259 |
|
2015 |
Maus F, Sakry D, Binamé F, Karram K, Rajalingam K, Watts C, Heywood R, Krüger R, Stegmüller J, Werner HB, Nave KA, Krämer-Albers EM, Trotter J. The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2. Plos One. 10: e0137311. PMID 26340347 DOI: 10.1371/Journal.Pone.0137311 |
0.259 |
|
2012 |
Piccirillo SGM, Spiteri I, Sottoriva A, Marko N, Tavare S, Collins P, Watts C. Abstract 3342: Tumor-initiating cells in human glioblastoma are heterogeneous populations which reside in distinct environmental niches Cancer Research. 72: 3342-3342. DOI: 10.1158/1538-7445.Am2012-3342 |
0.258 |
|
2016 |
Ma R, Watts C. Selective 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in Gliomas. Acta Neurochirurgica. PMID 27496021 DOI: 10.1007/S00701-016-2897-Y |
0.258 |
|
2012 |
Magister S, Obermajer N, Mirković B, Svajger U, Renko M, Softić A, Romih R, Colbert JD, Watts C, Kos J. Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells. European Journal of Cell Biology. 91: 391-401. PMID 22365146 DOI: 10.1016/J.Ejcb.2012.01.001 |
0.258 |
|
2014 |
Piccirillo SGM, Spiteri I, Sottoriva A, Touloumis A, Curtis C, Marioni J, Tavaer S, Watts C. O11 * TRANSCRIPTIONAL PROFILING OF DISTINCT COMPARTMENTS IN HUMAN GLIOBLASTOMA REVEALS KEY DYSREGULATED PATHWAYS Neuro-Oncology. 16: vi14-vi15. DOI: 10.1093/Neuonc/Nou250.11 |
0.258 |
|
2016 |
Watts C, Sanai N. Surgical approaches for the gliomas. Handbook of Clinical Neurology. 134: 51-69. PMID 26948348 DOI: 10.1016/B978-0-12-802997-8.00004-9 |
0.257 |
|
1989 |
West MA, Bretscher MS, Watts C. Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. Journal of Cell Biology. 109: 2731-2739. PMID 2556406 DOI: 10.1083/Jcb.109.6.2731 |
0.257 |
|
2012 |
Watts C. Surgical management of high-grade glioma: a standard of care. Cns Oncology. 1: 181-92. PMID 25057866 DOI: 10.2217/Cns.12.26 |
0.256 |
|
2008 |
Hamilton G, Colbert JD, Schuettelkopf AW, Watts C. Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis. The Embo Journal. 27: 499-508. PMID 18256700 DOI: 10.1038/Sj.Emboj.7601979 |
0.256 |
|
2009 |
Colbert JD, Matthews SP, Miller G, Watts C. Diverse regulatory roles for lysosomal proteases in the immune response. European Journal of Immunology. 39: 2955-65. PMID 19637232 DOI: 10.1002/Eji.200939650 |
0.256 |
|
2018 |
Mouliere F, Mair R, Chandrananda D, Marass F, Smith CG, Su J, Morris J, Watts C, Brindle KM, Rosenfeld N. Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. Embo Molecular Medicine. PMID 30401727 DOI: 10.15252/Emmm.201809323 |
0.256 |
|
2003 |
Manoury B, Mazzeo D, Li DN, Billson J, Loak K, Benaroch P, Watts C. Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. Immunity. 18: 489-98. PMID 12705852 DOI: 10.1016/S1074-7613(03)00085-2 |
0.256 |
|
2018 |
Kurian KM, Jenkinson MD, Brennan PM, Grant R, Jefferies S, Rooney AG, Bulbeck H, Erridge SC, Mills S, McBain C, McCabe MG, Price SJ, Marino S, Moyes E, Qian W, ... ... Watts C, et al. Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSG. Neuro-Oncology Practice. 5: 10-17. PMID 31385960 DOI: 10.1093/Nop/Npx022 |
0.256 |
|
2008 |
Zaru R, Mollahan P, Watts C. 3-phosphoinositide-dependent kinase 1 deficiency perturbs Toll-like receptor signaling events and actin cytoskeleton dynamics in dendritic cells. The Journal of Biological Chemistry. 283: 929-39. PMID 17991746 DOI: 10.1074/Jbc.M708069200 |
0.255 |
|
2011 |
Miller G, Matthews SP, Reinheckel T, Fleming S, Watts C. Asparagine endopeptidase is required for normal kidney physiology and homeostasis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 1606-17. PMID 21292981 DOI: 10.1096/Fj.10-172312 |
0.255 |
|
2003 |
Donovan T, Fryer TD, Peña A, Watts C, Carpenter TA, Pickard JD. Stereotactic MR imaging for planning neural transplantation: A reliable technique at 3 Tesla? British Journal of Neurosurgery. 17: 443-449. PMID 14635750 DOI: 10.1080/02688690310001613844 |
0.255 |
|
2018 |
Ma R, Chari A, Brennan PM, Alalade A, Anderson I, Solth A, Marcus HJ, Watts C. Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom. Neuro-Oncology Practice. 5: 74-81. PMID 31386018 DOI: 10.1093/Nop/Npx023 |
0.255 |
|
2015 |
Zaru R, Edgar AJ, Hanauer A, Watts C. Structural and functional basis for p38-MK2-activated Rsk signaling in toll-like receptor-stimulated dendritic cells. Molecular and Cellular Biology. 35: 132-40. PMID 25332232 DOI: 10.1128/Mcb.00773-14 |
0.255 |
|
2006 |
Schüttelkopf AW, Hamilton G, Watts C, van Aalten DM. Structural basis of reduction-dependent activation of human cystatin F. The Journal of Biological Chemistry. 281: 16570-5. PMID 16601115 DOI: 10.1074/Jbc.M601033200 |
0.254 |
|
2013 |
Cuadrado E, Jansen MH, Anink J, De Filippis L, Vescovi AL, Watts C, Aronica E, Hol EM, Kuijpers TW. Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutieres syndrome. Brain : a Journal of Neurology. 136: 245-58. PMID 23365100 DOI: 10.1093/Brain/Aws321 |
0.254 |
|
2004 |
Watts C. Immunology. The bell tolls for phagosome maturation. Science (New York, N.Y.). 304: 976-7. PMID 15143270 DOI: 10.1126/Science.1098573 |
0.254 |
|
2013 |
Walker D, Hamilton W, Walter FM, Watts C. Strategies to accelerate diagnosis of primary brain tumors at the primary-secondary care interface in children and adults. Cns Oncology. 2: 447-62. PMID 25054667 DOI: 10.2217/Cns.13.36 |
0.254 |
|
2011 |
Kenney-Herbert EM, Ball SL, Al-Mayhani TM, Watts C. Glioblastoma cell lines derived under serum-free conditions can be used as an in vitro model system to evaluate therapeutic response. Cancer Letters. 305: 50-7. PMID 21402437 DOI: 10.1016/J.Canlet.2011.02.025 |
0.253 |
|
2019 |
Walter FM, Penfold C, Joannides A, Saji S, Johnson M, Watts C, Brodbelt A, Jenkinson MD, Price SJ, Hamilton W, Scott SE. Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences. The British Journal of General Practice : the Journal of the Royal College of General Practitioners. PMID 30858332 DOI: 10.3399/Bjgp19X701861 |
0.253 |
|
1991 |
Watts C, Reid PA, Simitsek PD, West MA. Antigen processing and class II MHC-restricted antigen presentation in B-lymphocytes. Biochemical Society Transactions. 19: 263-5. PMID 1909663 DOI: 10.1042/Bst0190263 |
0.253 |
|
2015 |
Boonzaier NR, Piccirillo SG, Watts C, Price SJ. Assessing and monitoring intratumor heterogeneity in glioblastoma: how far has multimodal imaging come? Cns Oncology. PMID 26497327 DOI: 10.2217/Cns.15.20 |
0.253 |
|
2018 |
Al-Mayhani T, Heywood R, Vemireddy V, Lathia JD, Piccirillo SGM, Watts C. A Non-Hierarchical Organisation of Tumorigenic NG2 Cells in Glioblastoma promoted by EGFR. Neuro-Oncology. PMID 30590711 DOI: 10.1093/Neuonc/Noy204 |
0.253 |
|
2018 |
D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, ... ... Watts C, et al. The molecular landscape of glioma in patients with Neurofibromatosis 1. Nature Medicine. PMID 30531922 DOI: 10.1038/S41591-018-0263-8 |
0.253 |
|
2015 |
Zaru R, Matthews SP, Edgar AJ, Prescott AR, Gomez-Nicola D, Hanauer A, Watts C. The PDK1-Rsk Signaling Pathway Controls Langerhans Cell Proliferation and Patterning. Journal of Immunology (Baltimore, Md. : 1950). 195: 4264-72. PMID 26401001 DOI: 10.4049/Jimmunol.1501520 |
0.253 |
|
2019 |
Poisson L, Kouwenhoven MCM, Snyder J, Alfaro-Munoz K, Kaur M, Bates A, Verhaak R, Watts C, Zadeh G, Ryan Ormond D, Claus E, Khasraw M. EPID-23. PURSUIT OF AN INTERNATIONAL LANGUAGE OF GLIOMA RESEARCH: COMMON DATA ELEMENTS FOR THE LONGITUDINAL STUDY OF ADULT MALIGNANT GLIOMA Neuro-Oncology. 21: vi79-vi79. DOI: 10.1093/Neuonc/Noz175.323 |
0.253 |
|
1999 |
Pond L, Watts C. Functional early endosomes are required for maturation of major histocompatibility complex class II molecules in human B lymphoblastoid cells. Journal of Biological Chemistry. 274: 18049-18054. PMID 10364256 DOI: 10.1074/Jbc.274.25.18049 |
0.252 |
|
2019 |
Draaisma K, Chatzipli A, Taphoorn M, Kerkhof M, Weyerbrock A, Sanson M, Hoeben A, Lukacova S, Lombardi G, Leenstra S, Hanse M, Fleischeuer R, Watts C, McAbee J, Angelopoulos N, et al. Molecular Evolution of Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900367. PMID 31743054 DOI: 10.1200/Jco.19.00367 |
0.252 |
|
2012 |
van Kasteren S, Colbert J, Berlin I, Matthews S, Groettrup M, Mueller M, Keane D, Watts C. A pan-endosomal protease inhibitor attenuates endosomal function and improves antigen presentation Molecular Immunology. 51: 34. DOI: 10.1016/J.Molimm.2012.02.098 |
0.252 |
|
1997 |
Ferrari G, Knight AM, Watts C, Pieters J. Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules. The Journal of Cell Biology. 139: 1433-46. PMID 9396749 DOI: 10.1083/Jcb.139.6.1433 |
0.251 |
|
2002 |
Trivedi RA, Watts C, Kirkpatrick PJ, Gillard JH. Multiple cerebral aneurysms and the Diamond-Blackfan syndrome [5] Journal of Neurology Neurosurgery and Psychiatry. 72: 678-679. PMID 11971069 DOI: 10.1136/Jnnp.72.5.678 |
0.25 |
|
2017 |
Baird RD, Garcia-Corbacho J, Linossi C, Kumar SS, Smith D, Williams M, Qian W, Machin A, Ahmad S, Matys T, Jena R, Pacey S, Caldas C, Jodrell DI, Jefferies S, ... ... Watts C, et al. Cambridge Brain Mets Trial 1 (CamBMT1): A proof of principle study of afatinib penetration into cerebral metastases (mets) for patients (pts) undergoing neurosurgical resection, combined with low-dose, targeted radiotherapy (RT)—Phase 1b results. Journal of Clinical Oncology. 35: 2008-2008. DOI: 10.1200/Jco.2017.35.15_Suppl.2008 |
0.25 |
|
2001 |
Watts C. Antigen processing in the endocytic compartment Current Opinion in Immunology. 13: 26-31. PMID 11154913 DOI: 10.1016/S0952-7915(00)00177-1 |
0.249 |
|
2018 |
Kiesel B, M Thomé C, Weiss T, Jakola A, Darlix A, Pellerino A, Furtner J, Kerschbaumer J, Weller M, Pilkington G, Moyal EC, Henriksson R, Watts C, Rudà R, Reifenberger G, et al. CMET-26. PERIOPERATIVE IMAGING OF BRAIN METASTASES: A EUROPEAN ASSOCIATION OF NEURO-ONCOLOGY (EANO) YOUNGSTERS SURVEY Neuro-Oncology. 20: vi59-vi59. DOI: 10.1093/Neuonc/Noy148.238 |
0.249 |
|
2017 |
Chalmers A, Cruickshank G, Dunn L, Erridge S, Godfrey L, Herbert C, Jefferies S, Lopez J, McBain C, Pittman M, Sleigh R, Watts C, Webster-Smith M, Halford S. ACTR-16. RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM) Neuro-Oncology. 19: vi4-vi4. DOI: 10.1093/Neuonc/Nox168.012 |
0.249 |
|
2017 |
Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, Henriksson R, Rhun EL, Balana C, Chinot O, Bendszus M, Reijneveld JC, Dhermain F, French P, Marosi C, ... Watts C, et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. The Lancet. Oncology. PMID 28483413 DOI: 10.1016/S1470-2045(17)30194-8 |
0.249 |
|
2017 |
Baird R, Ramenatte N, Watts C, Jonson A, Jones L, Biggs H, Harrison E, Oberg I, Bullen G, Williams M, Qian W, Gilbert F, Jodrell D, Caldas C, Karabatsou K, et al. Abstract OT1-04-01: Cambridge brain mets trial 1 (CamBMT1): A proof-of-principle phase 1b / randomised phase 2 study of afatinib penetration into brain metastases for patients undergoing neurosurgical resection, both with and without prior low-dose, targeted radiotherapy Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-Ot1-04-01 |
0.248 |
|
1990 |
Reid PA, Watts C. Cell surface MHC glycoproteins cycle through primaquine sensitive intracellular compartments Cell Biology International Reports. 14: 240. DOI: 10.1016/0309-1651(90)91060-H |
0.248 |
|
2002 |
Watts C. Phagocytosis: how the phagosome became the phag-ER-some. Current Biology : Cb. 12: R666-8. PMID 12361588 DOI: 10.1016/S0960-9822(02)01163-6 |
0.248 |
|
2011 |
Borg N, Guilfoyle MR, Greenberg DC, Watts C, Thomson S. Serum albumin and survival in glioblastoma multiforme. Journal of Neuro-Oncology. 105: 77-81. PMID 21409514 DOI: 10.1007/S11060-011-0562-0 |
0.247 |
|
2018 |
Penfold C, Joannides AJ, Sage W, Brodbelt A, Jenkinson MD, Price S, Watts C, Bell J, Johnson M, Hamilton W, Walter FM. Understanding missed opportunities for more timely diagnosis of brain cancer – what can we learn from the BRACED qualitative interview study with adult glioma patients? Neuro-Oncology. 20: i2-i2. DOI: 10.1093/Neuonc/Nox237.005 |
0.247 |
|
2019 |
Zaccagna F, Riemer F, Priest AN, McLean MA, Allinson K, Grist JT, Dragos C, Matys T, Gillard JH, Watts C, Price SJ, Graves MJ, Gallagher FA. Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histology. European Radiology. PMID 30888488 DOI: 10.1007/S00330-019-6011-8 |
0.246 |
|
2008 |
West MA, Prescott AR, Chan KM, Zhou Z, Rose-John S, Scheller J, Watts C. TLR ligand-induced podosome disassembly in dendritic cells is ADAM17 dependent. The Journal of Cell Biology. 182: 993-1005. PMID 18762577 DOI: 10.1083/Jcb.200801022 |
0.246 |
|
2008 |
Liu Z, Jang SW, Liu X, Cheng D, Peng J, Yepes M, Li XJ, Matthews S, Watts C, Asano M, Hara-Nishimura I, Luo HR, Ye K. Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. Molecular Cell. 29: 665-78. PMID 18374643 DOI: 10.1016/J.Molcel.2008.02.017 |
0.246 |
|
2020 |
Hanna C, Kurian KM, Williams K, Watts C, Jackson A, Carruthers R, Strathdee K, Cruickshank G, Dunn L, Erridge S, Godfrey L, Jefferies S, McBain C, Sleigh R, McCormick A, et al. Pharmacokinetics, safety and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial. Neuro-Oncology. PMID 32347934 DOI: 10.1093/Neuonc/Noaa104 |
0.245 |
|
2006 |
Watts C. Phagosome neutrality in host defense. Cell. 126: 17-9. PMID 16839868 DOI: 10.1016/J.Cell.2006.06.031 |
0.245 |
|
2009 |
Colbert JD, Plechanovová A, Watts C. Glycosylation directs targeting and activation of cystatin f from intracellular and extracellular sources. Traffic (Copenhagen, Denmark). 10: 425-37. PMID 19192250 DOI: 10.1111/J.1600-0854.2009.00881.X |
0.244 |
|
1981 |
Goodman JM, Watts C, Wickner W. Membrane assembly: posttranslational insertion of M13 procoat protein into E. coli membranes and its proteolytic conversion to coat protein in vitro. Cell. 24: 437-41. PMID 7237555 DOI: 10.1016/0092-8674(81)90334-2 |
0.244 |
|
1997 |
Knight AM, Lucocq JM, Prescott AR, Ponnambalam S, Watts C. Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Ig(alpha)/Ig(beta) dimer. The Embo Journal. 16: 3842-50. PMID 9233794 DOI: 10.1093/Emboj/16.13.3842 |
0.244 |
|
2019 |
Casey RT, Ten Hoopen R, Ochoa E, Challis BG, Whitworth J, Smith PS, Martin JE, Clark GR, Rodger F, Maranian M, Allinson K, Madhu B, Roberts T, Campos L, Anstee J, ... ... Watts C, et al. SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice. Scientific Reports. 9: 10244. PMID 31308404 DOI: 10.1038/S41598-019-46124-9 |
0.243 |
|
2014 |
Edgar AJ, Trost M, Watts C, Zaru R. A combination of SILAC and nucleotide acyl phosphate labelling reveals unexpected targets of the Rsk inhibitor BI-D1870. Bioscience Reports. 34. PMID 27919044 DOI: 10.1042/Bsr20130094 |
0.243 |
|
1983 |
Watts C, Wickner W, Zimmermann R. M13 procoat and a pre-immunoglobulin share processing specificity but use different membrane receptor mechanisms Proceedings of the National Academy of Sciences of the United States of America. 80: 2809-2813. PMID 6344069 DOI: 10.1073/Pnas.80.10.2809 |
0.243 |
|
2010 |
Mattock KL, Gough PJ, Humphries J, Burnand K, Patel L, Suckling KE, Cuello F, Watts C, Gautel M, Avkiran M, Smith A. Legumain and cathepsin-L expression in human unstable carotid plaque. Atherosclerosis. 208: 83-9. PMID 19671471 DOI: 10.1016/J.Atherosclerosis.2009.07.022 |
0.242 |
|
2018 |
Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K, Wan JCM, Supernat A, Hudecova I, Gounaris I, Ros S, ... ... Watts C, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Science Translational Medicine. 10. PMID 30404863 DOI: 10.1126/Scitranslmed.Aat4921 |
0.242 |
|
2014 |
Watts C, Smith P, Wanek K, Counsell N. Preliminary evaluation of the tolerability and feasibility of combining 5-amino-levulinic acid (5-ALA) with carmustine wafers (Gliadel) in the surgical management of primary glioblastoma. Journal of Clinical Oncology. 32: 2081-2081. DOI: 10.1200/Jco.2014.32.15_Suppl.2081 |
0.241 |
|
2014 |
Collins JEC, Santarius T, Watts C, Walter FM, Price SJ, Joannides AJ. OP36 * CONCORDANCE OF PATIENT AND CLINICIAN REPORTED PRESENTING SYMPTOMS AT INITIAL NEURO-ONCOLOGY ASSESSMENT Neuro-Oncology. 16: vi22-vi22. DOI: 10.1093/Neuonc/Nou251.34 |
0.241 |
|
2016 |
Baird R, Garcia-Corbacho J, Ramenatte N, Jonson A, Ahmad S, Smith D, Qian W, Kumar S, Linossi C, Matys T, Graves M, Jodrell D, Caldas C, Pacey S, Whitfield G, ... ... Watts C, et al. CamBMT1: A proof-of-principle phase 1b / randomised phase 2 study of afatinib penetration into brain metastases (mets) for patients undergoing neurosurgical resection, both with and without prior low-dose, targeted radiotherapy Annals of Oncology. 27: vi132. DOI: 10.1093/Annonc/Mdw368.51 |
0.24 |
|
2007 |
Zaru R, Ronkina N, Gaestel M, Arthur JS, Watts C. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nature Immunology. 8: 1227-35. PMID 17906627 DOI: 10.1038/Ni1517 |
0.24 |
|
1981 |
Silver P, Watts C, Wickner W. Membrane assembly from purified components. I. Isolated M13 procoat does not require ribosomes or soluble proteins for processing by membranes Cell. 25: 341-345. PMID 7026042 DOI: 10.1016/0092-8674(81)90052-0 |
0.239 |
|
2001 |
Watts C, Amigorena S. Phagocytosis and antigen presentation. Seminars in Immunology. 13: 373-379. PMID 11708893 DOI: 10.1006/Smim.2001.0334 |
0.238 |
|
2013 |
Jefferies SJ, Harris FP, Price SJ, Collins VP, Watts C. High grade glioma--the arrival of the molecular diagnostic era for patients over the age of 65 years in the UK. Clinical Oncology (Royal College of Radiologists (Great Britain)). 25: 391-3. PMID 23615180 DOI: 10.1016/J.Clon.2013.03.005 |
0.238 |
|
2020 |
Sawlani V, Patel MD, Davies N, Flintham R, Wesolowski R, Ughratdar I, Pohl U, Nagaraju S, Petrik V, Kay A, Jacob S, Sanghera P, Wykes V, Watts C, Poptani H. Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesions. Insights Into Imaging. 11: 84. PMID 32681296 DOI: 10.1186/S13244-020-00888-1 |
0.238 |
|
2008 |
Watts C. Deep brain stimulation for Parkinson’s disease Acta Neurochirurgica. 150: 97-97. DOI: 10.1007/S00701-007-1449-X |
0.238 |
|
2016 |
Eskilsson E, Rosland GV, Talasila KM, Knappskog S, Keunen O, Sottoriva A, Foerster S, Solecki G, Taxt T, Jirik R, Fritah S, Harter PN, Välk K, Al Hossain J, Joseph JV, ... ... Watts C, et al. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro-Oncology. PMID 27286795 DOI: 10.1093/Neuonc/Now113 |
0.237 |
|
1989 |
Watts C, West MA, Reid PA, Davidson HW. Processing of immunoglobulin-associated antigen in B lymphocytes. Cold Spring Harbor Symposia On Quantitative Biology. 54: 345-52. PMID 2484164 DOI: 10.1101/Sqb.1989.054.01.042 |
0.235 |
|
1983 |
Watts C, Goodman JM, Silver P, Wickner W. Analysis of M13 procoat assembly into membranes in vitro. Methods in Enzymology. 97: 130-8. PMID 6361469 DOI: 10.1016/0076-6879(83)97126-4 |
0.235 |
|
2019 |
Fernández-Méndez R, Rastall RJ, Sage WA, Oberg I, Bullen G, Charge AL, Crofton A, Santarius T, Watts C, Price SJ, Brodbelt A, Joannides AJ. Quality improvement of neuro-oncology services: integrating the routine collection of patient-reported, health-related quality-of-life measures. Neuro-Oncology Practice. 6: 226-236. PMID 31385996 DOI: 10.1093/Nop/Npy040 |
0.235 |
|
2014 |
Gawden-Bone C, West MA, Morrison VL, Edgar AJ, McMillan SJ, Dill BD, Trost M, Prescott A, Fagerholm SC, Watts C. A crucial role for β2 integrins in podosome formation, dynamics and Toll-like-receptor-signaled disassembly in dendritic cells. Journal of Cell Science. 127: 4213-24. PMID 25086067 DOI: 10.1242/Jcs.151167 |
0.235 |
|
1978 |
Watts C, Wheeler KP. Protein and lipid components of the pigeon erythrocyte membrane. Biochemical Journal. 173: 899-907. PMID 708379 DOI: 10.1042/Bj1730899 |
0.234 |
|
2020 |
Noorani I, de la Rosa J, Choi Y, Strong A, Ponstingl H, Vijayabaskar MS, Lee J, Lee E, Richard-Londt A, Friedrich M, Furlanetto F, Fuente R, Banerjee R, Yang F, Law F, ... Watts C, et al. PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas. Genome Biology. 21: 181. PMID 32727536 DOI: 10.1186/S13059-020-02092-2 |
0.234 |
|
2011 |
Colbert JD, Matthews SP, Kos J, Watts C. Internalization of exogenous cystatin F supresses cysteine proteases and induces the accumulation of single-chain cathepsin L by multiple mechanisms. The Journal of Biological Chemistry. 286: 42082-90. PMID 21956111 DOI: 10.1074/Jbc.M111.253914 |
0.234 |
|
2016 |
Chalmers A, Jackson A, Swaisland H, Watts C, Halford S, Hargrave D, McCormick A. Ddis-19. Olaparib Penetrates Tumour Margins As Well As Contrast Enhancing Regions Of Glioblastoma At Therapeutic Levels: Interim Results Of The Oparatic Trial Nct01390571 Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.210 |
0.234 |
|
2015 |
Furtner J, Schöpf V, Seystahl K, Le Rhun E, Rudà R, Roelcke U, Koeppen S, Berghoff AS, Marosi C, Clement P, Faedi M, Watts C, Wick W, Soffietti R, Weller M, et al. Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. Neuro-Oncology. PMID 26354929 DOI: 10.1093/Neuonc/Nov183 |
0.234 |
|
2016 |
Langen KJ, Watts C. Neuro-oncology: Amino acid PET for brain tumours - ready for the clinic? Nature Reviews. Neurology. PMID 27282652 DOI: 10.1038/Nrneurol.2016.80 |
0.233 |
|
1997 |
Chen J, Dando PM, Rawlings ND, Brown MA, Young NE, Stevens RA, Hewitt E, Watts C, Barrett AJ. Cloning, Isolation, and Characterization of Mammalian Legumain, an Asparaginyl Endopeptidase Journal of Biological Chemistry. 272: 8090-8098. PMID 9065484 DOI: 10.1074/Jbc.272.12.8090 |
0.233 |
|
2018 |
Brazil L, Swampillai A, Mak K, Hackshaw A, Edwards D, Mesiri P, Clifton-Hadley L, Shaffer R, Lewis J, Watts C, Gkogkou P, Chalmers A, Fersht N, Short SC. P01.072 Hydroxychloroquine and short course radiotherapy for elderly patients with glioma: a randomised study Neuro-Oncology. 20: iii246-iii246. DOI: 10.1093/Neuonc/Noy139.114 |
0.233 |
|
2000 |
Emsley P, Fotinou C, Black I, Fairweather NF, Charles IG, Watts C, Hewitt E, Isaacs NW. The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. Journal of Biological Chemistry. 275: 8889-8894. PMID 10722735 DOI: 10.1074/Jbc.275.12.8889 |
0.231 |
|
2019 |
Jenkinson, Watts C, Marson A, Hill R, Murray K, Vale L, Bulbeck H, Grant R. TM1-1 Seizure prophylaxis in gliomas (SPRING): a phase III randomised controlled trial comparing prophylactic levetiracetam versus no prophylactic anti-epileptic drug in glioma surgery Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn.25 |
0.231 |
|
2019 |
Scott SE, Penfold C, Saji S, Curtis S, Watts C, Hamilton W, Joannides AJ, Walter FM. 'It was nothing that you would think was anything': Qualitative analysis of appraisal and help seeking preceding brain cancer diagnosis. Plos One. 14: e0213599. PMID 30901334 DOI: 10.1371/Journal.Pone.0213599 |
0.231 |
|
2006 |
Cheng T, Hitomi K, van Vlijmen-Willems IM, de Jongh GJ, Yamamoto K, Nishi K, Watts C, Reinheckel T, Schalkwijk J, Zeeuwen PL. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification. The Journal of Biological Chemistry. 281: 15893-9. PMID 16565075 DOI: 10.1074/Jbc.M600694200 |
0.231 |
|
2018 |
Chalmers AJ, Short S, Watts C, Herbert C, Morris A, Stobo J, Cruickshank G, Dunn L, Erridge S, Godfrey L, Jefferies S, Lopez JS, McBain C, Pittman M, Dillon S, et al. Phase I clinical trials evaluating olaparib in combination with radiotherapy (RT) and/or temozolomide (TMZ) in glioblastoma patients: Results of OPARATIC and PARADIGM phase I and early results of PARADIGM-2. Journal of Clinical Oncology. 36: 2018-2018. DOI: 10.1200/Jco.2018.36.15_Suppl.2018 |
0.23 |
|
2019 |
Kawsar KA, Inam MB, Watts C. Diabetes insipidus-an extremely rare complication from replacement of an external ventricular drain. Acta Neurochirurgica. PMID 31073783 DOI: 10.1007/S00701-019-03937-X |
0.23 |
|
2017 |
Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts C, Wick W, Wesseling P, Rudà R, Preusser M. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: iv84-iv99. PMID 28881917 DOI: 10.1093/Annonc/Mdx221 |
0.229 |
|
1981 |
Watts C, Silver P, Wickner W. Membrane assembly from purified components. II. Assembly of M13 procoat into liposomes reconstituted with purified leader peptidase Cell. 25: 347-353. PMID 7026043 DOI: 10.1016/0092-8674(81)90053-2 |
0.229 |
|
1985 |
Watts C. Rapid endocytosis of the transferrin receptor in the absence of bound transferrin Journal of Cell Biology. 100: 633-637. PMID 2857182 DOI: 10.1083/Jcb.100.2.633 |
0.228 |
|
2015 |
Kenney-Herbert E, Al-Mayhani T, Piccirillo SG, Fowler J, Spiteri I, Jones P, Watts C. CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population. Stem Cells Translational Medicine. 4: 822-31. PMID 26019225 DOI: 10.5966/Sctm.2014-0047 |
0.227 |
|
2004 |
Hensmann M, Li C, Moss C, Lindo V, Greer F, Watts C, Ogun SA, Holder AA, Langhorne J. Disulfide bonds in merozoite surface protein 1 of the malaria parasite impede efficient antigen processing and affect the in vivo antibody response. European Journal of Immunology. 34: 908. PMID 28748538 DOI: 10.1002/Eji.200490004 |
0.226 |
|
2016 |
Watts C, Jenkinson M, Ashkan K, Kurian K, Qian W, Machin A, Price S, Matys T, Doughton G. OS4.8 Improving the intra-operative diagnosis of high-grade glioma using a fluorescence biomarker - A Progress Report of The GALA-BIDD Study Neuro-Oncology. 18: iv11-iv11. DOI: 10.1093/Neuonc/Now188.034 |
0.223 |
|
1986 |
Watts C, Howard JC. Membrane recycling and antigen presentation Bioessays. 4: 265-267. PMID 3491608 DOI: 10.1002/Bies.950040607 |
0.223 |
|
2017 |
Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, Henriksson R, Rhun EL, Balana C, Chinot O, Bendszus M, Reijneveld JC, Dhermain F, French P, Marosi C, ... Watts C, et al. Evidence-based management of adult patients with diffuse glioma - Authors' reply. The Lancet. Oncology. 18: e430-e431. PMID 28759377 DOI: 10.1016/S1470-2045(17)30515-6 |
0.223 |
|
2010 |
Fael Al-Mayhani T, Kenney-Herbert E, Ichimura K, Collins V, Watts C. 532 NG2 expression identifies a tumour competent population in glioblastoma with distinct molecular signature European Journal of Cancer Supplements. 8: 136. DOI: 10.1016/S1359-6349(10)71333-1 |
0.223 |
|
1980 |
Watts C, Wheeler KP. The formation of vesicles retaining sodium-dependent transport systems for amino acids from protein-depleted membranes of pigeon erythrocytes. Biochimica Et Biophysica Acta. 602: 460-466. PMID 7426657 DOI: 10.1016/0005-2736(80)90324-7 |
0.222 |
|
2020 |
Price SJ, Joannides A, Plaha P, Afshari FT, Albanese E, Barua NU, Chan HW, Critchley G, Flannery T, Fountain DM, Mathew RK, Piper RJ, Poon MT, Rajaraman C, Rominiyi O, ... ... Watts C, et al. Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study). Bmj Open. 10: e040898. PMID 32801210 DOI: 10.1136/Bmjopen-2020-040898 |
0.221 |
|
2007 |
Mattock KL, Burnand K, Gough P, Patel L, Watts C, Taylor P, Smith A. Expression and activity of the cysteine protease, legumain, is up-regulated in unstable REGIONS OF human atherosclerotic plaques Atherosclerosis. 193. DOI: 10.1016/J.Atherosclerosis.2007.04.016 |
0.221 |
|
2015 |
Tavaré S, Sottoriva A, Piccirillo S, Spiteri I, Touloumis A, Marioni JC, Curtis CN, Watts C. Abstract IA04: Understanding tumor heterogeneity in glioblastoma Brain. 75. DOI: 10.1158/1538-7445.Brain15-Ia04 |
0.22 |
|
1981 |
Gain KR, Malthus R, Watts C. Glucose homeostasis during the perinatal period in normal rats and rats with a glycogen storage disorder. Journal of Clinical Investigation. 67: 1569-1573. PMID 7014637 DOI: 10.1172/Jci110188 |
0.219 |
|
1986 |
Watts C. Isolation and expression of cDNA clones for a rat liver asialoglycoprotein receptor Bioscience Reports. 6: 527-534. PMID 2945599 DOI: 10.1007/Bf01114949 |
0.218 |
|
2008 |
Watts C. Location, location, location: identifying the neighborhoods of LPS signaling. Nature Immunology. 9: 343-5. PMID 18349810 DOI: 10.1038/Ni0408-343 |
0.217 |
|
2017 |
Raiber E, Beraldi D, Cuesta SM, McInroy G, Kingsbury Z, Becq J, James T, Lopes M, Allinson K, Field S, Humphray S, Santarius T, Watts C, Bentley D, Balasubramanian S. GENE-46. COMPARISON OF MATCHED GLIOBLASTOMA TUMOR AND MARGIN SAMPLES USING SINGLE BASE RESOLUTION MAPS REVEALS ACQUIRED, EARLY EPIGENETIC CHANGES THAT PREDISPOSE TO MUTATIONS DURING TUMOURIGENESIS Neuro-Oncology. 19: vi102-vi102. DOI: 10.1093/Neuonc/Nox168.419 |
0.216 |
|
2018 |
Jenkinson MD, Barone DG, Bryant A, Vale L, Bulbeck H, Lawrie TA, Hart MG, Watts C. Intraoperative imaging technology to maximise extent of resection for glioma. The Cochrane Database of Systematic Reviews. 1: CD012788. PMID 29355914 DOI: 10.1002/14651858.Cd012788.Pub2 |
0.216 |
|
2018 |
Watts C, Ashkan K, Jenkinson M, Kurian K, Qian W, Price S, Matys T, Doughton G, Machin A, Jung J, Jalloh I, Harman C, Gatley K, Young G, Hardy R, et al. ACTR-59. IMPROVING THE INTRA-OPERATIVE DIAGNOSIS OF HIGH-GRADE GLIOMA USING A FLUORESCENCE BIOMARKER – RESULT OF THE GALA-BIDD STUDY Neuro-Oncology. 20: vi24-vi25. DOI: 10.1093/Neuonc/Noy148.090 |
0.216 |
|
1997 |
Hajduch E, Aledo JC, Watts C, Hundal HS. Proteolytic cleavage of cellubrevin and vesicle-associated membrane protein (VAMP) by tetanus toxin does not impair insulin-stimulated glucose transport or GLUT4 translocation in rat adipocytes Biochemical Journal. 321: 233-238. PMID 9003424 DOI: 10.1042/Bj3210233 |
0.215 |
|
2010 |
Demetriades AK, Demetriades CK, Watts C, Ashkan K. Brain-machine interface: the challenge of neuroethics. The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 8: 267-9. PMID 20709284 DOI: 10.1016/J.Surge.2010.05.006 |
0.215 |
|
2013 |
Watts C, Dunn L, Ashkan K, Jenkinson M, Smith P. Establishing the efficacy of Gliadel wafers: progress towards a Phase III trial. Acta Neurochirurgica. 155: 61-2. PMID 23108559 DOI: 10.1007/S00701-012-1533-8 |
0.215 |
|
2020 |
Narayan RS, Molenaar P, Teng J, Cornelissen FMG, Roelofs I, Menezes R, Dik R, Lagerweij T, Broersma Y, Petersen N, Marin Soto JA, Brands E, van Kuiken P, Lecca MC, Lenos KJ, ... ... Watts C, et al. A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities. Nature Communications. 11: 2935. PMID 32523045 DOI: 10.1038/S41467-020-16735-2 |
0.214 |
|
2018 |
Verhaak R, Consortium G, Aldape K, Amin S, Ashley D, Barnholtz-Sloan J, Bates A, Beroukhim R, Bock C, Brat D, Claus E, Costello J, de Groot J, Finocchiaro G, French P, ... ... Watts C, et al. DRES-05. MOLECULAR EVOLUTION OF DIFFUSE GLIOMAS AND THE GLIOMA LONGITUDINAL ANALYSIS CONSORTIUM Neuro-Oncology. 20: vi76-vi76. DOI: 10.1093/Neuonc/Noy148.312 |
0.213 |
|
2014 |
Heywood RM, Watts C. NG2/CSPG4 promotes proliferation and resistance to therapy in glioblastoma multiforme Annals of Medicine and Surgery. 3: 18. DOI: 10.1016/J.Amsu.2014.01.003 |
0.209 |
|
2005 |
Watts C. The Human Hippocampus Acta Neurochirurgica. 147: 1215-1215. DOI: 10.1007/S00701-005-0629-9 |
0.209 |
|
1982 |
Watts C, Gain K, Malthus R. Blood Glucose of Mother and Fetus during Late Pregnancy of Rats with a Glycogen Storage Disorder Neonatology. 41: 204-208. PMID 6950794 DOI: 10.1159/000241550 |
0.206 |
|
1980 |
Watts C, Wheeler KP. The characterisation of two partially purified systems for Na+-dependent amino acid transport Biochimica Et Biophysica Acta. 602: 446-459. PMID 7426656 DOI: 10.1016/0005-2736(80)90323-5 |
0.206 |
|
2017 |
Draaisma K, Chatzipli A, Taphoorn MJB, Kerkhof M, Weyerbrock A, Sanson M, Hoeben A, Slavka L, Lombardi G, Hanse MCJ, Fleischeuer R, Leenstra S, Watts C, Gorlia T, Golfinopoulos V, et al. Stability of Actionable Mutations in Primary and Recurrent Glioblastomas Neuro-Oncology. 18: 12-12. DOI: 10.1093/Neuonc/Now188.037 |
0.206 |
|
2008 |
Watts C. Advances in functional and reparative neurosurgery Acta Neurochirurgica. 150: 99-99. DOI: 10.1007/S00701-007-1450-4 |
0.206 |
|
2010 |
Watts C. A Concise Guide to Clinical Trials. By Allan Hackshaw. Chemmedchem. 5: 305-305. DOI: 10.1002/Cmdc.200900424 |
0.204 |
|
2017 |
Collord G, Tarpey P, Allinson K, Zakaria R, Hanemann O, Watts C, Dunn J, McDermott M, Price S, Ram Z, Behjati S, Castro M, Noorani I, Moran S, Esteller M, et al. GENE-13. AN INTEGRATED GENOMIC ANALYSIS OF ANAPLASTIC MENINGIOMA IDENTIFIES PROGNOSTIC MOLECULAR SIGNATURES Neuro-Oncology. 19: vi95-vi95. DOI: 10.1093/Neuonc/Nox168.388 |
0.204 |
|
1996 |
Robinson MS, Watts C, Zerial M. Membrane Dynamics in Endocytosis Cell. 84: 13-21. PMID 8548817 DOI: 10.1016/S0092-8674(00)80988-5 |
0.203 |
|
2018 |
Brodbelt A, Williams M, Thorpe A, Mills S, Price S, Lekka E, Watts C, Davis C, Jenkinson M. INNV-17. TUMOUR TREATING FIELDS: ACCEPTABLE TO A UK POPULATION? Neuro-Oncology. 20: vi141-vi142. DOI: 10.1093/Neuonc/Noy148.590 |
0.202 |
|
1984 |
Watts C, Gain KR. Insulin in the rat fetus. A new form of circulating insulin. Diabetes. 33: 50-56. PMID 6360767 DOI: 10.2337/Diab.33.1.50 |
0.202 |
|
2016 |
Watts C, Langen KJ. PET imaging in glioma: is it time for mainstream practice? Neuro-Oncology. 18: 1193-4. PMID 27563104 DOI: 10.1093/Neuonc/Now134 |
0.201 |
|
1998 |
Hämmerling GJ, Manoury B, Watts C, Adorini L, Lanzavecchia A. Peptide binding and editing: generation of TCR ligands. Research in Immunology. 149: 863-865. PMID 9923641 DOI: 10.1016/S0923-2494(99)80013-3 |
0.196 |
|
1978 |
Watts C, Wheeler KP. Partial separation of a sodium-dependent transport system for amino acids in avian erythrocyte membranes Febs Letters. 94: 241-244. PMID 700147 DOI: 10.1016/0014-5793(78)80946-6 |
0.195 |
|
2018 |
Wendler A, Perner J, Field S, Lynch A, Watts C, Tavare S. GENE-24. IMPACT OF THERAPY ON EVOLUTION OF GBM Neuro-Oncology. 20: vi108-vi108. DOI: 10.1093/Neuonc/Noy148.450 |
0.194 |
|
2013 |
Adachi K, Sasaki H, Nagahisa S, Yoshida K, Hattori N, Nishiyama Y, Kawase T, Hasegawa M, Abe M, Hirose Y, Alentorn A, Marie Y, Poggioli S, Alshehhi H, Boisselier B, ... ... Watts C, et al. OMICS AND PROGNSTIC MARKERS Neuro-Oncology. 15: iii136-iii155. DOI: 10.1093/Neuonc/Not183 |
0.193 |
|
1994 |
Lanzavecchia A, Watts C. Peptide partners call the tune Nature. 371: 198-199. PMID 8078577 DOI: 10.1038/371198A0 |
0.191 |
|
2018 |
Draaisma K, Chatzipli A, Taphoorn M, Kerkhof M, Weyerbrock A, Sanson M, Hoeben A, Lukacova S, Lombardi G, Hanse M, Fleisscheuer R, Leenstra S, Watts C, Gorlia T, Golfinopoulos V, et al. Path-42. Egfr-Amplified Idh-Wildtype Glioblastomas Seldom Transform Into A Hypermutated Phenotype Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.698 |
0.18 |
|
2013 |
Ryan DJ, Watts C. In vitro models of brain cancer Emerging Concepts in Neuro-Oncology. 2147483647: 75-86. DOI: 10.1007/978-0-85729-458-6_5 |
0.161 |
|
2022 |
Varn FS, Johnson KC, Martinek J, Huse JT, Nasrallah MP, Wesseling P, Cooper LAD, Malta TM, Wade TE, Sabedot TS, Brat D, Gould PV, Wöehrer A, Aldape K, Ismail A, ... ... Watts C, et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell. PMID 35649412 DOI: 10.1016/j.cell.2022.04.038 |
0.158 |
|
2022 |
Watts C. Lysosomes and lysosome-related organelles in immune responses. Febs Open Bio. PMID 35220694 DOI: 10.1002/2211-5463.13388 |
0.156 |
|
1997 |
Jolly PD, Smith PR, Heath DA, Hudson NL, Lun S, Still LA, Watts CH, McNatty KP. Morphological evidence of apoptosis and the prevalence of apoptotic versus mitotic cells in the membrana granulosa of ovarian follicles during spontaneous and induced atresia in ewes Biology of Reproduction. 56: 837-846. PMID 9096863 DOI: 10.1095/biolreprod56.4.837 |
0.153 |
|
2021 |
Watts C, Ashkan K, Jenkinson MD, Price SJ, Santarius T, Matys T, Zhang TT, Finch A, Collins P, Allinson K, Jefferies SJ, Scoffings DJ, Zisakis A, Phillips M, Wanek K, et al. An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma. Cancers. 13. PMID 34209555 DOI: 10.3390/cancers13133241 |
0.151 |
|
2021 |
Young AMH, Kumasaka N, Calvert F, Hammond TR, Knights A, Panousis N, Park JS, Schwartzentruber J, Liu J, Kundu K, Segel M, Murphy NA, McMurran CE, Bulstrode H, Correia J, ... ... Watts C, et al. A map of transcriptional heterogeneity and regulatory variation in human microglia. Nature Genetics. PMID 34083789 DOI: 10.1038/s41588-021-00875-2 |
0.148 |
|
2021 |
Tatla AS, Justin AW, Watts C, Markaki AE. A vascularized tumoroid model for human glioblastoma angiogenesis. Scientific Reports. 11: 19550. PMID 34599235 DOI: 10.1038/s41598-021-98911-y |
0.146 |
|
2021 |
Finch A, Solomou G, Wykes V, Pohl U, Bardella C, Watts C. Advances in Research of Adult Gliomas. International Journal of Molecular Sciences. 22. PMID 33477674 DOI: 10.3390/ijms22020924 |
0.141 |
|
2003 |
Watts C, Donovan T, Gillard JH, Antoun NM, Burnstein R, Menon DK, Carpenter TA, Fryer T, Thomas DGT, Pickard JD. Evaluation of an MRI-Based Protocol for Cell Implantation in Four Patients with Huntington's Disease. Cell Transplantation. 12: 697-704. PMID 28858590 DOI: 10.3727/000000003108747316 |
0.139 |
|
2020 |
Rezk R, Jia BZ, Wendler A, Dimov I, Watts C, Markaki AE, Franze K, Kabla AJ. Spatial heterogeneity of cell-matrix adhesive forces predicts human glioblastoma migration. Neuro-Oncology Advances. 2: vdaa081. PMID 32793884 DOI: 10.1093/noajnl/vdaa081 |
0.137 |
|
2021 |
Parkins CC, McAbee JH, Ruff L, Wendler A, Mair R, Gilbertson RJ, Watts C, Scherman OA. Mechanically matching the rheological properties of brain tissue for drug-delivery in human glioblastoma models. Biomaterials. 276: 120919. PMID 34419838 DOI: 10.1016/j.biomaterials.2021.120919 |
0.134 |
|
2021 |
Sun R, Cuthbert H, Watts C. Fluorescence-Guided Surgery in the Surgical Treatment of Gliomas: Past, Present and Future. Cancers. 13. PMID 34298721 DOI: 10.3390/cancers13143508 |
0.13 |
|
2022 |
Solomou G, Gharooni AA, Patel W, Gillespie CS, Gough M, Venkatesh A, Poon MTC, Wykes V, Price SJ, Jenkinson MD, Watts C, Plaha P. Utility of 5-ALA for resection of CNS tumours other than high-grade gliomas: a protocol for a systematic review. Bmj Open. 12: e056059. PMID 35868820 DOI: 10.1136/bmjopen-2021-056059 |
0.13 |
|
2020 |
McAbee JH, Degorre-Kerbaul C, Valdez K, Wendler A, Shankavaram UT, Watts C, Camphausen K, Tofilon PJ. Detection of glioblastoma intratumor heterogeneity in radiosensitivity using patient-derived neurosphere cultures. Journal of Neuro-Oncology. PMID 33057920 DOI: 10.1007/s11060-020-03643-0 |
0.129 |
|
2024 |
Abdelnabi D, Lastakchi S, Watts C, Atkins H, Hingtgen S, Valdivia A, McConville C. Local administration of irinotecan using an implantable drug delivery device stops high-grade glioma tumor recurrence in a glioblastoma tumor model. Drug Delivery and Translational Research. PMID 38319555 DOI: 10.1007/s13346-024-01524-x |
0.129 |
|
2023 |
Cuthbert H, Riley M, Bhatt S, Au-Yeung CK, Arshad A, Eladawi S, Zisakis A, Tsermoulas G, Watts C, Wykes V. Utility of a prognostic assessment tool to predict survival following surgery for brain metastases. Neuro-Oncology Practice. 10: 586-591. PMID 38026583 DOI: 10.1093/nop/npad047 |
0.129 |
|
2004 |
Hensmann M, Li C, Moss C, Lindo V, Greer F, Watts C, Ogun SA, Holder AA, Langhorne J. Disulfide bonds in merozoite surface protein 1 of the malaria parasite impede efficient antigen processing and affect the in vivo antibody response. European Journal of Immunology. 34: 639-48. PMID 14991593 DOI: 10.1002/eji.200324514 |
0.122 |
|
2021 |
Mouliere F, Smith CG, Heider K, Su J, van der Pol Y, Thompson M, Morris J, Wan JCM, Chandrananda D, Hadfield J, Grzelak M, Hudecova I, Couturier DL, Cooper W, Zhao H, ... ... Watts C, et al. Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients. Embo Molecular Medicine. e12881. PMID 34291583 DOI: 10.15252/emmm.202012881 |
0.121 |
|
2020 |
Brazil L, Swampillai AL, Mak KM, Edwards D, Mesiri P, Clifton-Hadley L, Shaffer R, Lewis J, Watts C, Jeffries S, Gkogkou P, Chalmers AJ, Fersht NL, Hackshaw A, Short SC. Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial Neuro-Oncology Advances. 2. DOI: 10.1093/noajnl/vdaa046 |
0.121 |
|
2015 |
Shearer RF, Iconomou M, Watts CK, Saunders DN. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer. Molecular Cancer Research : McR. 13: 1523-32. PMID 26464214 DOI: 10.1158/1541-7786.MCR-15-0383 |
0.12 |
|
2017 |
Halford SER, Cruickshank G, Dunn L, Erridge S, Godfrey L, Herbert C, Jefferies S, Lopez JS, McBain C, Pittman M, Sleigh R, Watts C, Webster-Smith MF, Chalmers AJ. Results of the OPARATIC trial: A phase I dose escalation study of olaparib in combination with temozolomide (TMZ) in patients with relapsed glioblastoma (GBM). Journal of Clinical Oncology. 35: 2022-2022. DOI: 10.1200/JCO.2017.35.15_suppl.2022 |
0.12 |
|
2022 |
Sun R, Sharma S, Benghiat H, Meade S, Sanghera P, Bramwell G, Nagaraju S, Pohl U, Dawson C, Petrik V, Ughratdar I, White A, Zisakis A, Ramalingam S, Sawlani V, ... Watts C, et al. Reconfiguration from emergency to urgent elective neurosurgery for glioblastoma patients improves length of stay, surgical adjunct use, and extent of resective surgery. Neuro-Oncology Practice. 9: 420-428. PMID 36127892 DOI: 10.1093/nop/npac034 |
0.119 |
|
2023 |
Hoogstrate Y, Draaisma K, Ghisai SA, van Hijfte L, Barin N, de Heer I, Coppieters W, van den Bosch TPP, Bolleboom A, Gao Z, Vincent AJPE, Karim L, Deckers M, Taphoorn MJB, Kerkhof M, ... ... Watts C, et al. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer Cell. PMID 36898379 DOI: 10.1016/j.ccell.2023.02.019 |
0.119 |
|
2023 |
Houweling M, Giczewska A, Abdul K, Nieuwenhuis N, Küçükosmanoglu A, Pastuszak K, Buijsman RC, Wesseling P, Wedekind L, Noske D, Supernat A, Bailey D, Watts C, Wurdinger T, Westerman BA. Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies. Neuro-Oncology Advances. 5: vdad073. PMID 37455945 DOI: 10.1093/noajnl/vdad073 |
0.117 |
|
2006 |
Butt AJ, Roberts CG, Seawright AA, Oelrichs PB, Macleod JK, Liaw TY, Kavallaris M, Somers-Edgar TJ, Lehrbach GM, Watts CK, Sutherland RL. A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells. Molecular Cancer Therapeutics. 5: 2300-9. PMID 16985064 DOI: 10.1158/1535-7163.MCT-06-0170 |
0.115 |
|
2021 |
Jenkins EPW, Finch A, Gerigk M, Triantis IF, Watts C, Malliaras GG. Electrotherapies for Glioblastoma. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2100978. PMID 34292672 DOI: 10.1002/advs.202100978 |
0.114 |
|
2020 |
Brazil L, Swampillai AL, Mak KM, Edwards D, Mesiri P, Clifton-Hadley L, Shaffer R, Lewis J, Watts C, Jeffries S, Gkogkou P, Chalmers AJ, Fersht NL, Hackshaw A, Short SC. Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial. Neuro-Oncology Advances. 2: vdaa046. PMID 32642699 DOI: 10.1093/noajnl/vdaa046 |
0.112 |
|
2022 |
Watts C, Savage J, Patel A, Mant R, Wykes V, Pohl U, Bulbeck H, Apps J, Sharpe R, Thompson G, Waldman AD, Ansorge O, Billingham L. Protocol for the Tessa Jowell BRAIN MATRIX Platform Study. Bmj Open. 12: e067123. PMID 36378622 DOI: 10.1136/bmjopen-2022-067123 |
0.112 |
|
2022 |
Retzer A, Sivell S, Scott H, Nelson A, Bulbeck H, Seddon K, Grant R, Adams R, Watts C, Aiyegbusi OL, Kearns P, Cruz Rivera S, Dirven L, Baddeley E, Calvert M, et al. Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study. Bmj Open. 12: e057712. PMID 36180121 DOI: 10.1136/bmjopen-2021-057712 |
0.112 |
|
2022 |
Millward CP, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Crofton A, Dirven L, Georgious T, Grundy PL, Islim AI, Javadpour M, Keshwara SM, Koszdin SD, Marson AG, ... ... Watts C, et al. Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings. Bmj Open. 12: e057384. PMID 35534067 DOI: 10.1136/bmjopen-2021-057384 |
0.11 |
|
2022 |
Olubajo F, Thorpe A, Davis C, Sinha R, Crofton A, Mills SJ, Williams M, Jenkinson MD, Price SJ, Watts C, Brodbelt AR. Tumour treating fields in glioblastoma: is the treatment tolerable, effective, and practical in UK patients? British Journal of Neurosurgery. 1-7. PMID 35200077 DOI: 10.1080/02688697.2022.2028722 |
0.109 |
|
2020 |
Wykes V, Zisakis A, Irimia M, Ughratdar I, Sawlani V, Watts C. Importance and Evidence of Extent of Resection in Glioblastoma. Journal of Neurological Surgery. Part a, Central European Neurosurgery. PMID 33049795 DOI: 10.1055/s-0040-1701635 |
0.108 |
|
2007 |
Munoz MA, Saunders DN, Henderson MJ, Clancy JL, Russell AJ, Lehrbach G, Musgrove EA, Watts CK, Sutherland RL. The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints. Cell Cycle (Georgetown, Tex.). 6: 3070-7. PMID 18073532 DOI: 10.4161/cc.6.24.5021 |
0.107 |
|
2004 |
Saunders DN, Hird SL, Withington SL, Dunwoodie SL, Henderson MJ, Biben C, Sutherland RL, Ormandy CJ, Watts CK. Edd, the murine hyperplastic disc gene, is essential for yolk sac vascularization and chorioallantoic fusion. Molecular and Cellular Biology. 24: 7225-34. PMID 15282321 DOI: 10.1128/MCB.24.16.7225-7234.2004 |
0.104 |
|
2003 |
Eblen ST, Kumar NV, Shah K, Henderson MJ, Watts CK, Shokat KM, Weber MJ. Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs. The Journal of Biological Chemistry. 278: 14926-35. PMID 12594221 DOI: 10.1074/Jbc.M300485200 |
0.099 |
|
2006 |
Nahum A, Zeller L, Danilenko M, Prall OW, Watts CK, Sutherland RL, Levy J, Sharoni Y. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. European Journal of Nutrition. 45: 275-82. PMID 16565789 DOI: 10.1007/s00394-006-0595-x |
0.099 |
|
2020 |
Lu Y, Patel M, Natarajan K, Ughratdar I, Sanghera P, Jena R, Watts C, Sawlani V. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma. Magnetic Resonance Imaging. PMID 32980505 DOI: 10.1016/j.mri.2020.09.017 |
0.095 |
|
2021 |
Booth TC, Thompson G, Bulbeck H, Boele F, Buckley C, Cardoso J, Dos Santos Canas L, Jenkinson D, Ashkan K, Kreindler J, Huskens N, Luis A, McBain C, Mills SJ, Modat M, ... ... Watts C, et al. A Position Statement on the Utility of Interval Imaging in Standard of Care Brain Tumour Management: Defining the Evidence Gap and Opportunities for Future Research. Frontiers in Oncology. 11: 620070. PMID 33634034 DOI: 10.3389/fonc.2021.620070 |
0.095 |
|
2023 |
Bozzao A, Weber D, Crompton S, Braz G, Csaba D, Dhermain F, Finocchiaro G, Flannery T, Kramm C, Law I, Marucci G, Oliver K, Ostgathe C, Paterra R, Pesce G, ... ... Watts C, et al. European Cancer Organisation Essential Requirements for Quality Cancer Care: adult glioma. Journal of Cancer Policy. 100438. PMID 37634617 DOI: 10.1016/j.jcpo.2023.100438 |
0.093 |
|
2022 |
Millward CP, Armstrong TS, Barrington H, Brodbelt AR, Bulbeck H, Byrne A, Dirven L, Gamble C, Grundy PL, Islim AI, Javadpour M, Keshwara SM, Krishna ST, Mallucci CL, Marson AG, ... ... Watts C, et al. Opportunities and Challenges for the development of 'Core Outcome Sets' in Neuro-Oncology. Neuro-Oncology. PMID 35287168 DOI: 10.1093/neuonc/noac062 |
0.093 |
|
2022 |
Plaha P, Camp S, Cook J, McCulloch P, Voets N, Ma R, Taphoorn MJB, Dirven L, Grech-Sollars M, Watts C, Bulbeck H, Jenkinson MD, Williams M, Lim A, Dixon L, et al. FUTURE-GB: functional and ultrasound-guided resection of glioblastoma - a two-stage randomised control trial. Bmj Open. 12: e064823. PMID 36379652 DOI: 10.1136/bmjopen-2022-064823 |
0.093 |
|
2000 |
Eyre JA, Miller S, Clowry GJ, Conway EA, Watts C. Functional corticospinal projections are established prenatally in the human foetus permitting involvement in the development of spinal motor centres Brain. 123: 51-64. PMID 10611120 |
0.093 |
|
1996 |
Gilligan JH, Treasure T, Watts C. Incorporating psychometric measures in selecting and developing surgeons Journal of Management in Medicine. 10: 5-16, 2. PMID 10538032 |
0.092 |
|
1999 |
Gilligan JH, Welsh FKS, Watts C, Treasure T. Square pegs in round holes: Has psychometric testing a place in choosing a surgical career? A preliminary report of work in progress Annals of the Royal College of Surgeons of England. 81: 73-79. PMID 10364959 |
0.091 |
|
2022 |
Zaccagna F, McLean MA, Grist JT, Kaggie J, Mair R, Riemer F, Woitek R, Gill AB, Deen S, Daniels CJ, Ursprung S, Schulte RF, Allinson K, Chhabra A, Laurent MC, ... ... Watts C, et al. Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle Study. Radiology. Imaging Cancer. 4: e210076. PMID 35838532 DOI: 10.1148/rycan.210076 |
0.088 |
|
2014 |
Brooke DG, van Dam EM, Watts CK, Khoury A, Dziadek MA, Brooks H, Graham LJ, Flanagan JU, Denny WA. Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3). Bioorganic & Medicinal Chemistry. 22: 1029-39. PMID 24398380 DOI: 10.1016/j.bmc.2013.12.041 |
0.086 |
|
2002 |
Henderson MJ, Russell AJ, Hird S, Muñoz M, Clancy JL, Lehrbach GM, Calanni ST, Jans DA, Sutherland RL, Watts CK. EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response. The Journal of Biological Chemistry. 277: 26468-78. PMID 12011095 DOI: 10.1074/jbc.M203527200 |
0.086 |
|
2013 |
Watts C. Emerging concepts in neuro-oncology Emerging Concepts in Neuro-Oncology. 2147483647: 1-220. DOI: 10.1007/978-0-85729-458-6 |
0.085 |
|
2018 |
Brodbelt A, Williams M, Thorpe A, Mills S, Price S, Lekka E, Watts C, Davis C, Jenkinson M. A PILOT STUDY OF THE ACCEPTANCE AND TOLERABILITY OF TUMOUR TREATING FIELDS IN ADULT GLIOBLASTOMA PATIENTS Neuro-Oncology. 20: v349-v349. DOI: 10.1093/neuonc/noy129.023 |
0.083 |
|
2003 |
Watts C. In Vivo Atlas of Deep Brain Structures British Journal of Neurosurgery. 17: 110-110. DOI: 10.1080/0268869031000093906 |
0.078 |
|
2023 |
Watts C, Dayimu A, Matys T, Ashkan K, Price S, Jenkinson MD, Doughton G, Mather C, Young G, Qian W, Kurian KM. Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study Report. Journal of Personalized Medicine. 13. PMID 36983696 DOI: 10.3390/jpm13030514 |
0.077 |
|
2023 |
Retzer A, Baddeley E, Sivell S, Scott H, Nelson A, Bulbeck H, Seddon K, Grant R, Adams R, Watts C, Aiyegbusi OL, Kearns P, Rivera SC, Dirven L, Calvert M, et al. Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study. Neuro-Oncology Advances. 5: vdad096. PMID 37719788 DOI: 10.1093/noajnl/vdad096 |
0.076 |
|
2003 |
Clancy JL, Henderson MJ, Russell AJ, Anderson DW, Bova RJ, Campbell IG, Choong DY, Macdonald GA, Mann GJ, Nolan T, Brady G, Olopade OI, Woollatt E, Davies MJ, Segara D, ... ... Watts CK, et al. EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene. 22: 5070-81. PMID 12902990 DOI: 10.1038/Sj.Onc.1206775 |
0.074 |
|
2022 |
Love SB, Cafferty F, Snowdon C, Carty K, Savage J, Pallmann P, McParland L, Brown L, Masters L, Schiavone F, Hague D, Townsend S, Amos C, South A, Sturgeon K, ... ... Watts C, et al. Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units. Trials. 23: 757. PMID 36068599 DOI: 10.1186/s13063-022-06680-4 |
0.073 |
|
2020 |
Noorani I, de la Rosa J, Choi YH, Strong A, Ponstingl H, Vijayabaskar MS, Lee J, Lee E, Richard-Londt A, Friedrich M, Furlanetto F, Fuente R, Banerjee R, Yang F, Law F, ... Watts C, et al. Correction to: PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas. Genome Biology. 21: 206. PMID 32799926 DOI: 10.1186/s13059-020-02127-8 |
0.071 |
|
2021 |
Pepper J, Cuthbert H, Scott T, Ughratdar I, Wykes V, Watts C, D'Urso P, Karabatsou K, Moor CC, Albanese E. Seizure Outcome after surgery for Insula High Grade Glioma. World Neurosurgery. PMID 34343689 DOI: 10.1016/j.wneu.2021.07.114 |
0.071 |
|
2021 |
Fountain DM, Bryant A, Barone DG, Waqar M, Hart MG, Bulbeck H, Kernohan A, Watts C, Jenkinson MD. Intraoperative imaging technology to maximise extent of resection for glioma: a network meta-analysis. The Cochrane Database of Systematic Reviews. 1: CD013630. PMID 33428222 DOI: 10.1002/14651858.CD013630.pub2 |
0.07 |
|
2023 |
Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N, Platten M, Galanis E, Lim M, Wen PY, Minniti G, Colman H, Cloughesy TF, Mehta MP, Geurts M, ... ... Watts C, et al. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nature Medicine. PMID 37488293 DOI: 10.1038/s41591-023-02464-8 |
0.068 |
|
2006 |
Henderson MJ, Munoz MA, Saunders DN, Clancy JL, Russell AJ, Williams B, Pappin D, Khanna KK, Jackson SP, Sutherland RL, Watts CK. EDD mediates DNA damage-induced activation of CHK2. The Journal of Biological Chemistry. 281: 39990-40000. PMID 17074762 DOI: 10.1074/jbc.M602818200 |
0.068 |
|
2021 |
Fountain DM, Piper RJ, Poon MTC, Solomou G, Brennan PM, Chowdhury YA, Colombo F, Elmoslemany T, Ewbank FG, Grundy PL, Hasan MT, Hilling M, Hutchinson PJ, Karabatsou K, Kolias AG, ... ... Watts C, et al. CovidNeuroOnc: A UK multicenter, prospective cohort study of the impact of the COVID-19 pandemic on the neuro-oncology service. Neuro-Oncology Advances. 3: vdab014. PMID 34056602 DOI: 10.1093/noajnl/vdab014 |
0.064 |
|
2022 |
Solomou G, Venkatesh A, Patel W, Chari A, Mohan M, Bandyopadhyay S, Gillespie CS, Mendoza N, Watts C, Jenkins A. A career in neurosurgery: perceptions and the impact of a national SBNS/NANSIG neurosurgery careers day. British Journal of Neurosurgery. 1-7. PMID 35603975 DOI: 10.1080/02688697.2022.2076807 |
0.062 |
|
2011 |
Watts CK, Saunders DN. Effects of EDD on p53 function are context-specific. The Journal of Biological Chemistry. 286: le13; author reply l. PMID 21757764 DOI: 10.1074/jbc.L110.182527 |
0.059 |
|
2018 |
Ma R, Chari A, Brennan PM, Alalade A, Anderson I, Solth A, Marcus HJ, Watts C. Corrigenda: Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom. Neuro-Oncology Practice. 5: 72. PMID 31408511 DOI: 10.1093/nop/npy017 |
0.058 |
|
2007 |
Ohshima R, Ohta T, Wu W, Koike A, Iwatani T, Henderson M, Watts CK, Otsubo T. Putative tumor suppressor EDD interacts with and up-regulates APC. Genes to Cells : Devoted to Molecular & Cellular Mechanisms. 12: 1339-45. PMID 18076571 DOI: 10.1111/j.1365-2443.2007.01138.x |
0.054 |
|
2021 |
Hoogstrate Y, Ghisai SA, de Wit M, de Heer I, Draaisma K, van Riet J, van de Werken HJG, Bours V, Buter J, Vanden Bempt I, Eoli M, Franceschi E, Frenel JS, Gorlia T, Hanse MC, ... ... Watts C, et al. The EGFRvIII transcriptome in glioblastoma, a meta-omics analysis. Neuro-Oncology. PMID 34608482 DOI: 10.1093/neuonc/noab231 |
0.051 |
|
2013 |
Edgar AJ, Trost M, Watts C, Zaru R. A combination of SILAC and nucleotide acyl phosphate labelling reveals unexpected targets of the Rsk inhibitor BI-D1870. Bioscience Reports. PMID 24341623 DOI: 10.1042/BSR20130094 |
0.05 |
|
2021 |
Toman E, Soon WC, Thanabalasundaram G, Burns D, Petrik V, Watts C, Wykes V, White A. Comparison of outcomes of neurosurgical operations performed before and during the COVID-19 pandemic: a matched cohort study. Bmj Open. 11: e047063. PMID 33622958 DOI: 10.1136/bmjopen-2020-047063 |
0.049 |
|
2013 |
Mair R, Watts C. Anti-angiogenesis in glioblastoma: The clinical consequences of redundancy and evasion? Current Angiogenesis. 2: 126-134. DOI: 10.2174/2211552802666140128000111 |
0.049 |
|
2006 |
Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA. Progressive prothrombotic state in women with advancing HIV disease Journal of Acquired Immune Deficiency Syndromes. 42: 572-577. PMID 16837864 DOI: 10.1097/01.qai.0000230320.78288.79 |
0.043 |
|
2013 |
Watts CK, Daly RJ. Professor Robert Sutherland FAA, AO (1947-2012). Hormone Molecular Biology and Clinical Investigation. 16: 113-4. PMID 25436862 DOI: 10.1515/hmbci-2013-0046 |
0.039 |
|
2015 |
Piccirillo SG, Sottoriva A, Watts C. The role of sub-ventricular zone in gliomagenesis. Aging. 7: 738-9. PMID 26527608 |
0.01 |
|
Hide low-probability matches. |